Annual Statements Open main menu

AXT INC - Annual Report: 2003 (Form 10-K)

e10vk
Table of Contents



UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-K

     
(Mark One)
   
þ
  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the fiscal year ended December 31, 2003
 
OR
 
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
    For the transition period from           to

Commission file number: 0-24085

AXT, Inc.

(Exact name of registrant as specified in its charter)
     
Delaware
  94-3031310
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
 
4281 Technology Drive,
Fremont, California
(Address of principal executive offices)
  94538
(Zip Code)

Registrant’s telephone number, including area code:

(510) 683-5900

Securities registered pursuant to Section 12(b) of the Act:

None

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $.001 par value

      Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes þ          No o

      Indicate by checkmark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.     Yes o          No þ

      Indicate by checkmark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act.).     Yes o          No þ

      The aggregate market value of the voting stock held by non-affiliates of the registrant, based upon the closing sale price of the common stock on June 30, 2003 as reported on the Nasdaq National Market, was approximately $20,120,644. Shares of common stock held by each officer, director and by each person who owns 5% or more of the outstanding common stock have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not a conclusive determination for other purposes.

      As of January 31, 2003, 22,960,606 shares, $.001 par value, of the registrant’s common stock were outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

      Portions of the definitive proxy statement for the registrant’s 2004 annual meeting of stockholders to be filed with the Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this form are incorporated by reference into Part III of this Form 10-K report.




TABLE OF CONTENTS

         
 PART I
   Business   1
   Properties   9
   Legal Proceedings   9
   Submission of Matters to a Vote of Security Holders   10
 PART II
   Market for Registrant’s Common Equity and Related Stockholder Matters   10
   Selected Consolidated Financial Data   10
   Management’s Discussion and Analysis of Financial Condition and Results of Operations   13
   Quantitative and Qualitative Disclosures About Market Risk   34
   Consolidated Financial Statements and Supplementary Data   34
   Changes in and Disagreements with Accountants on Accounting and Financial Disclosures   36
   Controls and Procedures   36
 PART III
   Directors and Executive Officers of the Registrant   37
   Executive Compensation   37
   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters   37
   Certain Relationships and Related Transactions   37
   Principal Accountant Fees and Services   38
 PART IV
   Exhibits, Financial Statement Schedules, and Reports on Form 8-K   39
 EXHIBIT 10.17
 EXHIBIT 31.1
 EXHIBIT 31.2
 EXHIBIT 32.1
 EXHIBIT 32.2


Table of Contents

PART I

      Some of the information set forth in this annual report are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements, including statements as to industry trends, our future expectations and other matters that do not relate strictly to historical facts, are based on certain assumptions made by management. These statements are often identified by the use of words such as “may,” “will,” “expect,” “plans,” “believe,” “anticipate,” “intend,” “could,” “estimate,” or “continue” and similar expressions or variations, and are based on the beliefs and assumptions of our management based on information then currently available to management. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from the forward-looking statements include, among others, the risks discussed below under “Risks Related to Our Business.” These factors are not intended to represent a complete list of the general or specific factors that may affect us. It should be recognized that other factors, including general economic factors and business strategies, may be significant, presently or in the future, and may affect us to a greater extent than indicated. Such forward-looking statements speak only as of the date on which such statements are made; except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.

 
Item 1. Business — Overview

      We design, develop, manufacture and distribute high-performance compound semiconductor substrates comprising gallium arsenide (GaAs), indium phosphide (InP) and germanium (Ge). Our substrate products are used primarily in wireless communications, lighting display applications, and fiber optic communications. We believe our proprietary vertical gradient freeze, or VGF, technique for manufacturing compound semiconductor substrates provides significant benefits over other methods and has enabled us to become a leading manufacturer of compound semiconductor substrates. We pioneered the commercial use of VGF technology to manufacture GaAs substrates and subsequently used VGF technology to manufacture substrates from InP, and Ge. Some of our competitors followed our lead by developing their own versions of VGF technology. Customers for our substrates include United Epitaxy Company, Motorola, Agilent Technologies, Samsung, EMCORE, Kopin, IQE, and Sumika. Over the past four years, we have implemented an initiative, which is now largely complete, to reduce the cost of manufacturing our substrates by moving most of our operations to China and by investing in sources of low cost raw materials.

      On June 24, 2003, the Company’s Board of Directors approved management’s plan to exit the Company’s unprofitable opto-electronics business. The disposition was a result of continuing operating losses and negative cash flows from the division and significant uncertainty regarding future profitability.

      We were incorporated in California in December 1986 and reincorporated in Delaware in May 1988. We changed our name from American Xtal Technology, Inc. to AXT, Inc. in July 2000. Our principal offices are located at 4281 Technology Drive, Fremont, California 94538, and our telephone number at this address is (510) 683-5900. Our web site is www.axt.com; however, the information on our web site does not constitute a part of this annual report on Form 10-K and is not incorporated herein. We make available, free of charge, on or through our web site, our annual, quarterly and current reports, and any amendments to those reports.

Industry Background

      Historically, most semiconductors were created on a single crystal base material, or substrate, of silicon. Today, however, many electronic and opto-electronics semiconductors are being developed with requirements that exceed the capabilities of silicon. These semiconductors address the continually increasing demand to send, receive and display information on high-speed wireless and wireline networks. This demand creates a growing need for power-efficient high-performance semiconductors that can operate at high frequencies and can be produced cost-effectively in large volumes. These semiconductors enable the growth and development of a wide range of end user applications. For example, Gartner, Inc., an independent research firm, expects

1


Table of Contents

worldwide mobile terminal production to grow from approximately 510 million units in 2003 to approximately 560 million units in 2004.

      Other examples of applications for these systems include:

  •  voice and high-speed wireless data systems;
 
  •  infrared emitters and optical detectors in computer systems;
 
  •  fiber optic networks and optical systems within these networks;
 
  •  selected wi-fi networks
 
  •  solid-state lighting, including exterior and interior automobile lighting; and
 
  •  satellite communications systems.

      As a result of the limitations of silicon-based technologies, semiconductor device manufacturers use compound semiconductor substrates to improve the performance of semiconductor devices and to enable these new applications. This use occurs even though these compound semiconductor substrates are more expensive than silicon. Compound semiconductor substrates are composed of multiple elements that include a metal, such as gallium, aluminum or indium, and a non-metal, such as arsenic, phosphorus or nitrogen. The resulting compounds include gallium arsenide, indium phosphide and gallium nitride. Advantages of devices manufactured on compound substrates over devices manufactured using silicon substrates include:

  •  operation at higher speeds;
 
  •  lower power consumption;
 
  •  less noise and distortion; and
 
  •  opto-electronic properties that enable devices to emit and detect light.

      A key step in producing a compound semiconductor substrate is to grow a crystal of the materials. Historically, two processes were used to grow crystals: the Liquid Encapsulated Czochralski, or LEC, technique and the Horizontal-Bridgeman, or HB, technique. We believe two trends reduced the appeal of these techniques: more semiconductor devices are being formed using an epitaxial process and semiconductor device manufacturers are switching their production lines to larger diameter substrates, including six-inch diameters for electronic device applications and three- and four-inch for opto-electronic device applications. The LEC and HB techniques each have difficulties producing high quality, low-cost compound semiconductor substrates for epitaxial processing. Substrates produced using the LEC technique have a high volume of defects as size increases beyond four-inches in diameter. The HB technique has been unable to reliably produce substrates more than three-inches in diameter.

      We introduced our VGF technique in 1986 to respond to the limitations inherent in the LEC and HB techniques, and, in recent years, some of our competitors who previously relied on the LEC or HB methods have also developed their own versions of VGF. We believe that a majority of the substrates sold commercially in 2003 for electronic device applications were manufactured using the VGF or similar techniques.

      Compound semiconductor substrates enable the development of a wide range of electronic products including power amplifiers and radio frequency integrated circuits used in wireless handsets. Compound substrates can also be used to create opto-electronic products including high brightness light emitting diodes, or HBLEDs, and vertical cavity surface emitting lasers, or VCSELs, used in solid-state lighting and fiber optic communications, respectively.

2


Table of Contents

The AXT Advantage

      We are a leading developer and supplier of high-performance compound semiconductor substrates. There are three key causes of our success:

      Our VGF technology is a competitive advantage. We pioneered the commercial use of VGF technology to manufacture GaAs substrates and we believe that through the use of VGF we became a leading worldwide supplier of GaAs substrates. Our VGF process produces substrates with high mechanical strength and physical and chemical uniformity, as well as low crystal defect densities. The following changes in our customers’ technologies are increasing the share of substrates sold with these features:

  •  Greater use of epitaxy rather than ion implantation. Many of the newest generation of high-performance semiconductor devices for fiber optic and wireless communications applications, including heterojunction bipolar transistors, or HBTs, and pseudomorphic high electron mobility transistors, or PHEMTs, are popular because they offer lower power consumption and better device linearity than their predecessors. These devices are created using epitaxial processed substrates. Our VGF substrates are more suitable for these applications than are products manufactured using LEC and HB technologies, and competing materials such as silicon germanium, or SiGe.
 
  •  Switch to six-inch diameter wafers. Many semiconductor device manufacturers switched their GaAs production lines to six-inch diameter substrates in order to reduce unit costs and increase capacity. We were among the first competitors able to deliver large volumes of six-inch diameter VGF substrates and retain a significant amount of manufacturing capacity for this product.
 
  •  Customer technology independence. Our semiconductor device manufacturing customers often compete among themselves. For example, several of our customers compete for technological leadership in the wireless handset market. These customers or end-users all manufacture their devices on GaAs substrates. We are, therefore, largely immune from the effects of such competition and benefit from an overall need for faster, more power efficient electronic and opto-electronic devices.

      Some customers specify VGF substrates. Our wafers are qualified with many of the key suppliers of GaAs and InP semiconductor devices. The qualification process, which is lengthy and must be repeated for each customer, can be a barrier to entry for a new material or supplier. Furthermore, certain of our customers now effectively specify that they will only accept VGF-grown or equivalent substrates for their manufacturing processes. The lengthy qualification period benefits us when we are already qualified with a customer, but acts as a barrier to entry for those customers with which we are not qualified.

      Our low-cost manufacturing is an advantage. In 1998, we began moving portions of our substrate manufacturing operations to China, to benefit from a combination of lower costs for facilities, labor and materials than we encounter in the United States. That move continued and as of the end of 2003, most of our substrate manufacturing activities occur in China. We have also made some strategic investments in raw materials producers, including one that produces gallium, that provide us with a secured and low cost source of important materials and enables us to market surplus production to others. We believe this provides us with a cost advantage vis-à-vis our competitors, which do not enjoy similar arrangements.

3


Table of Contents

Technology

      Our core technologies include our proprietary VGF technique used to produce high quality crystals that are processed into compound substrates, and our gallium extraction technology which allows us to extract raw gallium from aluminum ore.

(VGF FURNACE DIAGRAM)

      Our VGF technique is designed to control the crystal-growth process with minimal temperature variation and is the technique we use to produce our GaAs, InP and Ge substrates. Unlike traditional techniques, our VGF technique places the hot compound melt above the cool crystal, thereby reducing the turbulence at the interface of the melt and the solid crystal, compared with the LEC technique in which the melt and crystal are inverted. The temperature gradient between the melt and the crystal in the VGF technique is significantly lower than in traditional techniques. These aspects of the VGF technique enable us to grow crystals that have a relatively low defect density and high uniformity. The crystal and the resulting substrate are mechanically strong, resulting in lower breakage rates during a customer’s manufacturing process. Since the temperature gradient is controlled electronically rather than by physical movement, the sensitive crystal is not disturbed as it may be during some competitors’ VGF-like growth processes. In addition, the melt and growing crystal are contained in a closed chamber, which isolates the crystal from the outside environment to reduce potential contamination. This substrate isolation allows for more precise control of the gallium-to-arsenic ratio, resulting in better consistency and uniformity of the crystals.

      Our VGF technique offers several benefits when compared to traditional crystal growing technologies. The Liquid Encapsulated Czochralski, or LEC, technique is the traditional method for producing semi-insulating GaAs substrates for electronic applications. During the LEC process, the crystal is grown by dipping a seed crystal through molten boric oxide into a melt and slowly pulling the seed up into the cool zone above the boric oxide where the crystal hardens. Unlike the VGF technique, the LEC technique is designed so that the hotter GaAs melt is located beneath the cooler crystal, resulting in greater turbulence in the melt, and at a temperature gradient that is significantly higher than the VGF technique. The turbulence and high temperature cause LEC-grown crystals to have a higher dislocation density than VGF-grown crystals, resulting in a higher rate of breakage during the device manufacturing process. As an open process, the LEC technique also results in greater propensity for contamination and difficulty controlling the ratio of gallium to

4


Table of Contents

arsenic. It requires large, complex electro-mechanical systems that are expensive and require highly skilled personnel to operate. Strategy Analytics, a third-party market research firm, estimated that approximately 60 percent of the GaAs substrates sold in 2002 by all competitors to customers that manufacture electronic devices were manufactured using VGF or similar techniques. They projected that VGF’s share would increase to approximately 70 percent by 2007.

      Our VGF technique also offers advantages over the Horizontal-Bridgeman, or HB, technique, for producing semi-conducting GaAs substrates for opto-electronic applications. The HB technique holds the GaAs melt in a semi-cylindrical container, causing crystals grown using the HB method to have a semi-circular, or D-shaped, cross-section. Accordingly, more crystal material is discarded when the D-shaped substrate is subsequently trimmed to a round shape. In addition, crystals grown using the HB technique have a higher defect density than VGF-grown crystals. The HB technique cannot be used cost-effectively to produce substrates greater than three inches in diameter. The HB technique houses the GaAs melt in a quartz container during the growth process, which can contaminate the GaAs melt with silicon impurities, making it unsuitable for producing semi-insulating GaAs substrates.

      The following table provides a comparison of these three techniques: LEC remains about 40% of the semi-insulating market and HB is still present in the semi-conducting market.

             
VGF HB LEC



Substrate applications
  Electronic and opto-electronic   Opto-electronic   Electronic
Largest wafer size available
  6”   3”   6”
Stress/defect levels
  Very Low   Low   High
Crystal purity
  Good   Poor   Good
Applicability to multiple materials
  GaAs, InP, Ge   GaAs   GaAs, InP, GaP
Equipment and labor cost
  Very Low   Low   High
Amount of waste material
  Very Low   High   Low
Equipment flexibility
  Versatile   Limited   Limited
Equipment downtime
  Minimal   Moderate   High
Number of competitors
  Several   Declining   Declining

Products

      We design, develop, manufacture and distribute high-performance semiconductor substrates. The table below sets forth our products and selected applications:

         
Product Applications


Substrates
  Electronic   Opto-electronic
GaAs
  • Cellular phones   • LEDs
    • Direct broadcast television   • Lasers
    • High-performance transistors   • Optical couplers
    • Satellite communications    
 
InP
  • Fiber optic communications   • Lasers
    • Satellite communications    
    • High-performance transistors    
    • Automotive collision avoidance radars    
 
Ge
  • Satellite solar cells    

      Substrates. We currently sell compound substrates manufactured from GaAs and InP, as well as single-element substrates manufactured from Ge. We supply GaAs substrates in two-, three-, four-, five- and

5


Table of Contents

six-inch diameters. We manufacture InP substrates in two-, three- and four-inch diameters and Ge substrates in four-inch diameters.

      Materials. We sell 99.99% pure gallium. We began selling Ga in 2001, primarily through our majority owned subsidiary, Beijing Ji Ya Semiconductor Material Company, Ltd. We sell primarily to re-processors who improve the purity of the gallium. In 2003 sales of gallium were approximately $3.3 million.

Customers

      We sell our compound semiconductor substrates and materials worldwide. Our customers include:

         
Advanced Epitaxy Technology
  Kingmax   Sumika
Agilent Technologies
  Kopin   Triquent Semiconductor
Coherent Tutcore
  Motorola   Uni Light Technology
EMCORE
  Osram   Visual Photonics Epitaxy
Honeywell
  Opto-Power   United Epitaxy Company
IQE, Inc.
  Procomp Informatics   Xiamen Shanan Electronics
Isotech
  Recapture Metals    

      Historically, we have sold a significant portion of our products in any particular period to a limited number of customers. No customer represented greater than 10% of product revenues for the years ended December 31, 2003, 2002 and 2001. The company’s top five customers represented 28.9% of product revenue for the year ended December 31, 2003, 31.4% of product revenue for the year ended December 31, 2002, and 31.1% of product revenue for the year ended December 31, 2001. We expect that sales to certain customers will continue to comprise a significant portion of our revenue in the future.

Manufacturing, Raw Materials and Supplies

      We believe that our results are partially due to our manufacturing efficiency and high product yields and we continually emphasize quality and process control throughout our manufacturing operations. We perform our substrate manufacturing operations at our facilities in Beijing, China and Fremont, California. As part of our plan to reduce substrate manufacturing costs, we shifted the vast majority of our manufacturing processes to our facilities in China, where costs are generally lower, by the end of 2003. We currently perform research and development and limited manufacturing in our Fremont, California facilities. We believe that our capital investment and subsequent operating costs are lower for our manufacturing facilities in China relative to the U.S. Many of our manufacturing operations are fully automated and computer monitored or controlled, enhancing reliability and yield. We use proprietary equipment in our substrate manufacturing operations to protect our intellectual property and control the timing and pace of capacity additions. All of our manufacturing facilities are ISO 9001 or 9002 certified.

      Although we purchase supply parts, components and raw materials from several domestic and international suppliers, we depend on a single or limited number of suppliers for certain critical materials used in the production of our substrates, such as quartz tubing, polishing solutions, and paralytic boron nitride. We generally purchase these materials through standard purchase orders and not pursuant to long-term supply contracts. Although we seek to maintain sufficient inventory levels of certain materials to guard against interruptions in supply and to meet our near term needs, and have to date been able to obtain sufficient supplies of materials in a timely manner, there may be shortages of certain key materials, such as gallium. Accordingly, to help ensure continued supply of materials, we formed joint ventures with and made investments in some suppliers of key raw materials required to manufacture our products, including gallium. We believe that these joint ventures and investments will be advantageous in procuring materials to support our growth. In addition, excess capacity is marketed to others.

6


Table of Contents

Sales and Marketing

      We advertise in trade publications, distribute promotional materials, conduct marketing and sales programs, and participate in industry trade shows and conferences in order to raise market awareness of our products. We sell our substrate products through our direct sales force in the U.S. and Japan and through independent sales representatives in France, Japan, South Korea, Taiwan and the United Kingdom. Our direct sales force consists of sales engineers who are knowledgeable in the manufacture and use of compound and single-element substrates. Our sales engineers work with customers during all stages of the substrate manufacturing process, from developing the precise composition of the substrate through manufacturing and processing the substrate to the customer’s exact specifications. We believe that maintaining a close relationship with customers and providing them with ongoing technical support improves customer satisfaction and will provide us with a competitive advantage in selling other substrates to our customers. The substrate division launched a program in late 2000 with selected customers in which we guaranteed that certain volumes of six-inch GaAs and other substrates would be delivered on specific dates and the customer made a prepayment for part of the value of its order. Several major customers participate in this program. At December 31, 2003, the unearned pre-payments we retained under this program equaled $1.0 million. We do not expect to continue this program after the pre-payments currently in hand are utilized by customers.

      International Sales. International sales are an important part of our business. In the year ended December 31, 2003, sales to customers outside of the United States accounted for 65.9% of our revenue, as compared with 43.9% in 2002 and with 47.5% in 2001. The primary markets for sales of our products outside of the United States include countries in Asia and Western Europe. Our ability to sustain and increase our international sales involves significant risks, including volatile political, social and economic instabilities abroad, possible fluctuations in currency exchange rates, and changes in tariffs, import restrictions or other trade barriers.

Research and Development

      To maintain and improve our competitive position, we focus our research and development efforts on designing new proprietary processes and products, improving the performance of existing products and reducing manufacturing costs. We have assembled a multi-disciplinary team of highly skilled scientists, engineers and technicians to meet our research and development objectives.

      Our current substrate research and development activities focus on continued development and enhancement of GaAs, InP and Ge substrates, including improved yield, enhanced surface characteristics and uniformity, greater substrate strength and increased crystal length. During 2003 we experienced surface quality problems with our GaAs substrates for some customers.

      Research and development expenses were $1.3 million in 2003, compared with $2.3 million in 2002, and $3.9 million in 2001. We believe that our current rate of expenditure can enable us to achieve our research and development goals.

Competition

      The semiconductor substrate industry is characterized by rapid technological change and price erosion, as well as intense foreign and domestic competition. We believe we currently have a leading position in the existing markets for compound semiconductor substrates primarily as a result of our expertise in VGF technology. However, we believe we face actual and potential competition from a number of established domestic and international companies who have advantages not available to us.

      We believe that the primary competitive factors in the markets in which our substrate products compete are:

  •  quality;
 
  •  price;
 
  •  performance;

7


Table of Contents

  •  meeting customer specifications; and
 
  •  customer support and satisfaction.

      Our ability to compete in target markets also depends on factors such as:

  •  the timing and success of the development and introduction of new products and product features by us and our competitors;
 
  •  the availability of adequate sources of raw materials; and
 
  •  protection of our products by effective use of intellectual property laws and general economic conditions.

      Our primary competition in the market for compound semiconductor substrates includes Freiberger, Japan Energy and Sumitomo Electric. In addition, we also face competition from compound semiconductor device manufacturers that produce substrates for their own internal use, including Hitachi, and from companies such as IBM that are actively developing alternative compound semiconductor materials.

Protection of our Intellectual Property

      Our success and the competitive position of our VGF technique depend on our ability to maintain trade secrets and other intellectual property protections. We rely on a combination of patents, trademark and trade secret laws, non-disclosure agreements and other intellectual property protection methods to protect our proprietary technology. We believe that, due to the rapid pace of technological innovation in the markets for our products, our ability to establish and maintain a position of technology leadership depends as much on the skills of our development personnel as upon the legal protections afforded our existing technologies. To protect our trade secrets, we take certain measures to ensure their secrecy, such as executing non-disclosure agreements with our employees, customers and suppliers. However, reliance on trade secrets is only an effective business practice insofar as trade secrets remain undisclosed and a proprietary product or process is not reverse engineered or independently developed.

      To date, we have been issued 4 U.S. patents and have 4 U.S. patent applications pending, which relate to our VGF products and processes. We have 9 patent applications pending (in PCT/national stage process) in Europe, Canada, China, Japan and South Korea which are based on our U.S. patents that relate to our VGF processes. We have 1 issued foreign patent.

Environmental Regulations

      We are subject to federal, state and local environmental laws and regulations. These laws, rules and regulations govern the use, storage, discharge and disposal of hazardous chemicals during manufacturing, research and development and sales demonstrations. If we fail to comply with applicable regulations, we could be subject to substantial liability for clean-up efforts, personal injury and fines or suspension or cessation of our operations. We cooperated with the California Occupational Safety and Health Administration, or Cal-OSHA, in an investigation primarily regarding impermissible levels of potentially hazardous materials in certain areas of our manufacturing facility in Fremont, California. In May 2000, Cal-OSHA levied a fine against us in the amount of $313,655 for alleged health and safety violations. In March 2001, we settled this claim in the amount of $200,415, and have put in place engineering, administrative and personnel protective equipment programs to address these issues. On May 1, 2001, the Santa Clara Center for Occupational Safety and Health (SCCOSH) filed a complaint for injunctive relief and civil penalties against us alleging violations of California Business Professions Code 17200 et seq., and Health and Safety Code section 25249 et seq. as a result of our use of arsenic and inorganic arsenic compounds in our workplace. We reached a settlement with SCCOSH during 2002.

Employees

      As of December 31, 2003, we had 972 employees, of whom 818 were principally engaged in manufacturing, 141 in sales and administration, and 13 in research and development. Of these employees, 119

8


Table of Contents

are located in the U.S., 852 in China and 1 in Japan. As a result of shifting more of our substrate manufacturing to China, we implemented headcount reductions in our Fremont, California facilities, and expect further reductions as our shift of manufacturing activities to China is completed. Our employees are not represented by a union and we have never experienced a work stoppage. Although morale has been affected by our workforce reductions, we consider our relations with our employees to be good.
 
Item 2. Properties

      Our principal properties as of March 15, 2004 are as follows:

                 
Square
Location Feet Principal Use Ownership




Fremont, CA
    80,000     Production   Owned
Fremont, CA
    14,441     Administration   Operating lease, expires May 2005
Fremont, CA
    9,280     Warehouse   Operating lease, expires June 2005
Fremont, CA
    24,100     Warehouse   Operating lease, expires July 2006
Fremont, CA
    55,000     Production and Administration   Operating lease, expires March 2013
Monterey Park, CA
    22,000     Vacant   Owned; available for sale
El Monte, CA
    5,600     Production   Operating lease, expires December 2006
Beijing, China
    31,000     Production and Administration   Owned
Beijing, China
    31,000     Production   Owned
Beijing, China
    32,000     Production   Owned
Beijing, China
    16,000     Housing   Owned
Beijing, China
    34,000     Production   Owned
Beijing, China
    48,000     Production   Owned
Beijing, China
    22,000     Production and Administration   Owned
Beijing, China
    53,000     Production   Owned; under construction
Xianshee, China
    56,500     Production   Owned by Beijing Ji Ya Semiconductor Materials, Co., Ltd.
Xianshee, China
    7,500     Administration   Owned by Beijing Ji Ya Semiconductor Materials, Co., Ltd.
Xianshee, China
    1,000     Administration   Owned by Beijing Ji Ya Semiconductor Materials, Co., Ltd.
Nanjing, China
    22,000     Production   Owned by Nanjing Jin Mei Gallium Co., Ltd.
Nanjing, China
    5,700     R&D and Administration   Owned by Nanjing Jin Mei Gallium Co., Ltd.
Nanjing, China
    3,900     Production   Owned by Nanjing Jin Mei Gallium Co., Ltd.
Beijing, China
    7,600     Production and Administration   Owned by Beijing Bo Yu Semiconductor Vessel Craftwork Technology

      We consider each facility to be in good operating condition and adequate for its present use, and believe that each facility has sufficient plant capacity to meet its current and anticipated operating requirements.

 
Item 3. Legal Proceedings

      From time to time we are involved in judicial or administrative proceedings concerning matters arising in the ordinary course of our business. We do not expect that any of these matters, individually or in the aggregate, will have a material adverse effect on our business, financial condition, cash flows or results of operation.

9


Table of Contents

      On April 15, 2003, Sumitomo Electric Industries, Ltd., (SEI) filed a complaint in the Tokyo District Court, Civil Division against us and our Japanese distributor alleging patent infringement of two patents held by SEI in Japan. The suit seeks penalties from AXT in the amount of $1.67 million plus interest and court costs and the cessation of AXT’s sales of gallium arsenide substrates in Japan. AXT intends to defend itself vigorously in these lawsuits and continues to sell its products in Japan.

      On June 11, 2003, Cree, Inc. filed a complaint in the United States Court for Northern District of California against us alleging patent infringement. The complaint sought damages and injunction against infringement. On July 23, 2003, we filed a counter complaint in the United States Court for Northern District of California, denying any patent infringement and alleging that Cree’s actions were intentionally designed to interfere with our prospective business relationships. We reached an agreement with Cree resolving the disputes between us and signed a settlement agreement on March 5, 2004. The resolution of the disputes did not have a material adverse impact on the Company’s consolidated financial position or results of operations.

 
Item 4. Submission of Matters to a Vote of Security Holders

      None

PART II

 
Item 5. Market for Registrant’s Common Equity and Related Stockholder Matters

      Our common stock has been trading publicly on the Nasdaq National Market under the symbol “AXTI” since May 20, 1998, the date we consummated our initial public offering. The following table sets forth, for the periods indicated, the range of quarterly high and low closing sales prices for our common stock on the Nasdaq National Market.

                   
High Low


Fiscal 2003
               
 
First Quarter ended March 31, 2003
  $ 1.950     $ 0.670  
 
Second Quarter ended June 30, 2003
  $ 1.650     $ 0.680  
 
Third Quarter ended September 30, 2003
  $ 3.120     $ 1.200  
 
Fourth Quarter ended December 31, 2003
  $ 3.420     $ 1.890  
 
Fiscal 2002
               
 
First Quarter ended March 31, 2002
  $ 16.890     $ 8.850  
 
Second Quarter ended June 30, 2002
  $ 11.600     $ 7.000  
 
Third Quarter ended September 30, 2002
  $ 8.390     $ 2.080  
 
Fourth Quarter ended December 31, 2002
  $ 2.820     $ 0.970  

      As of December 31, 2003, there were 121 holders of record of our common stock. Because many shares of AXT’s common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders.

      We have never paid or declared any cash dividends on our common stock and do not anticipate paying cash dividends in the foreseeable future. Dividends accrue on our outstanding Series A preferred stock at the rate of $0.20 per annum per share of Series A preferred stock.

 
Item 6. Selected Consolidated Financial Data

      The following selected consolidated financial data are derived from and should be read in conjunction with our consolidated financial statements and related notes set forth in Item 8 below, and in our previously filed reports on Form 10-K. See also Item 7 “Management’s Discussion and Analysis of Financial Condition

10


Table of Contents

and Results of Operations” for further information relating to items reflecting our results of operations and financial condition.
                                             
Years Ended December 31,

2003 2002 2001 2000 1999





(In thousands, except per share data)
Income Statement Data:
                                       
Revenue
  $ 34,713     $ 44,865     $ 108,800     $ 113,374     $ 56,732  
Cost of revenue
    32,478       53,758       67,494       61,361       33,446  
     
     
     
     
     
 
Gross profit (loss)
    2,235       (8,893 )     41,306       52,013       23,286  
Operating expenses:
                                       
 
Selling, general, and administrative
    10,475       13,860       17,208       13,619       6,194  
 
Research and development
    1,337       2,339       3,876       4,307       2,007  
 
Restructuring costs
          14,632                    
 
Acquisition costs
                            2,810  
     
     
     
     
     
 
   
Total operating expenses
    11,812       30,831       21,084       17,926       11,011  
     
     
     
     
     
 
Income (loss) from operations
    (9,577 )     (39,724 )     20,222       34,087       12,275  
Interest expense
    466       437       831       2,357       1,431  
Other (income) and expense, net
    1,050       12,703       13,379       (28,463 )     (1,308 )
     
     
     
     
     
 
Income (loss) from continuing operations before provision for income taxes
    (11,093 )     (52,864 )     6,012       60,193       12,152  
Provision for income taxes
          2,119       2,164       22,874       5,685  
     
     
     
     
     
 
Income (loss) from continuing operations
    (11,093 )     (54,983 )     3,848       37,319       6,467  
Discontinued operations:
                                       
 
Loss from discontinued operations
    (6,163 )     (34,625 )     (13,818 )     (22,264 )     (7,092 )
 
Loss on disposal
    (9,475 )                 (1,341 )      
 
Benefit for income taxes
          (8,427 )     (4,974 )     (7,896 )     (1,305 )
     
     
     
     
     
 
Loss from discontinued operations
    (15,638 )     (26,198 )     (8,844 )     (15,709 )     (5,787 )
Extraordinary item, net of tax benefits
                            (508 )
     
     
     
     
     
 
Net income (loss)
  $ (26,731 )   $ (81,181 )   $ (4,996 )   $ 21,610     $ 172  
     
     
     
     
     
 
Basic income (loss) per share:
                                       
 
Income (loss) from continuing operations
  $ (0.49 )   $ (2.46 )   $ 0.17     $ 1.90     $ 0.35  
 
Loss from discontinued operations
    (0.69 )     (1.17 )     (0.40 )     (0.80 )     (0.31 )
 
Extraordinary item
                            (0.03 )
 
Net income (loss)
    (1.18 )     (3.63 )     (0.23 )     1.10       0.01  
Diluted income (loss) per share:
                                       
 
Income (loss) from continuing operations
  $ (0.49 )   $ (2.46 )   $ 0.17     $ 1.77     $ 0.33  
 
Loss from discontinued operations
    (0.69 )     (1.17 )     (0.39 )     (0.75 )     (0.29 )
 
Extraordinary item
                            (0.03 )
 
Net income (loss)
    (1.18 )     (3.63 )     (0.23 )     1.03       0.01  
Shares used in per share calculations:
                                       
 
Basic
    22,781       22,433       22,278       19,677       18,655  
 
Diluted
    22,781       22,433       22,879       21,059       19,771  

11


Table of Contents

                                         
December 31,

2003 2002 2001 2000 1999





(In thousands)
Balance Sheet Data:
                                       
Cash and cash equivalents
  $ 24,339     $ 13,797     $ 37,538     $ 68,585     $ 6,062  
Short-term investments
    14,669       8,205       25,673       30,852        
Working capital
    57,335       65,375       125,295       140,387       40,462  
Restricted deposits
    9,302       11,150                    
Long-term investments
          3,657       6,552              
Total assets
    107,023       145,667       243,359       250,220       115,762  
Long-term capital lease, net of current portion
          4,847       10,002       7,278       6,853  
Long-term debt, net of current portion
    8,842       13,289       14,342       15,123       15,254  
Stockholders’ equity
    82,298       105,657       186,322       185,347       62,459  

      All periods have been restated to reflect the accounting for discontinued operations. As a result, the discontinued opto-electronics and consumer products divisions have been eliminated from continuing operations in the income statements.

12


Table of Contents

      Item 7.     Management’s Discussion and Analysis of Financial Condition and Results of Operations

      The following discussion and analysis of our financial condition and results of operations should be read in conjunction with “Selected Consolidated Financial Data” and our consolidated financial statements and related notes included elsewhere in this Form 10-K. In addition to historical information, the discussion in this Form 10-K contains forward-looking statements that involve risks and uncertainties that could cause our actual results to differ materially from those projected. The statements contained in the Report on Form 10-K that are not purely historical are forward looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, including, without limitation, statements regarding our expectations, beliefs, intentions or strategies regarding the future. All forward-looking statements included in this Report on Form 10-K are based on information available to us on the date hereof, and we assume no obligation to update any such forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results to differ materially from those implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continues” or the negative of these terms or other comparable terminology. Factors that might cause or contribute to such differences include, but are not limited to, those set forth under “Risks Related to Our Business” and elsewhere in this Form 10-K.

Overview

      We were founded in 1986 to commercialize and enhance our proprietary vertical gradient freeze (VGF) technique for producing high-performance compound semiconductor substrates. Upon the discontinuance of our opto-electronics division, and the sale of substantially all of the assets of this business in 2003, we now have one operating segment: our substrate division. We made our first substrate sales in 1990 and our substrate division currently sells gallium arsenide (GaAs) and indium phosphide (InP) substrates to manufacturers of semiconductor devices for use in applications such as fiber optic and wireless telecommunications, light emitting diodes (LEDs) and lasers. We also sell raw materials including gallium and germanium through our participation in majority- and minority-owned joint ventures. We have the capability to manufacture germanium substrates for use in satellite solar cells but withdrew from this business during 2000 so that we could more profitably use our then constrained capacity. We are now trying to re-qualify our germanium substrates with the few existing satellite solar cell system manufacturers.

      Our total revenue from continuing operations was $34.7 million for 2003, $44.9 million for 2002 and $108.8 million for 2001. In 2003 we incurred a loss from operations of $9.6 million compared to a loss of $39.7 million for 2002 and income of $20.2 million for 2001.

      On June 24, 2003, we announced the discontinuation of our opto-electronics division, which we established as part of our acquisition of Lyte Optronics, Inc. in May 1999. Accordingly, the results of operations of the opto-electronics division have been segregated from continuing operations and are reported separately as discontinued operations in our consolidated statements of operations for all periods presented (see Note 2 to our consolidated financial statements for details regarding the accounting for discontinued operations). The discontinued opto-electronics division manufactured blue, cyan, and green high-brightness light emitting diodes (HBLEDs) for the illumination markets, including full-color displays, wireless handset backlighting and traffic signals, and also manufactured vertical cavity surface emitting lasers (VCSELs) and laser diodes for fiber optic communications and storage area networks.

      On September 27, 2003 we completed a sale of substantially all of the assets of our opto-electronics business to Lumei Optoelectronics, Corp. and Dalian Luming Science and Technology Group, Co., Ltd. for the Chinese Renminbi (RMB) equivalent of $9.6 million. Sale proceeds of $1.0 million will be held in escrow for up to one year and will not be recorded until all claims, if any, are settled. If unclaimed, up to $250,000 of the sale proceeds will be held in escrow for a second year and will not be recorded until all claims, if any, are settled. We retain a building located in Monterey Park, CA, that we expect to sell in 2004. This asset is classified as Held for Sale on our consolidated balance sheet at December 31, 2003.

13


Table of Contents

      Our continuing business, primarily sales of our substrate products, is dependant on the semiconductor industry, which is highly cyclical and has historically experienced downturns both as a result of economic changes and of overcapacity. We experienced a growth period that lasted from our initiation of sales in 1990 through the first half of 2001. In the second half of 2001, we experienced a $44.9 million, or 58.5% decrease in revenue compared to the first half as a result of the rapid decline in the mobile and fiber optic telecommunications markets. Together with other industry participants, we experienced lower revenues, slower bookings, push outs and cancellation of orders. As such, we recorded losses in the third and fourth quarters of 2001.

      During the first half of 2002 our revenues grew due to improvements in the wireless market. In the second half of 2002 our revenue fell, however, because the substrate industry was still facing excess capacity that caused prices to decline, and because we experienced a loss of market share after two competitors developed technologies similar to ours. In addition, certain customers selected competitors’ products in order to diversify their supply sources and due to the belief that the competitors’ substrates offered better surface qualities. Full year 2002 revenue declined $63.9 million, or 58.8% compared to 2001. We recorded losses in each quarter of 2002 and incurred impairment charges against fixed assets and inventory due to the decline in demand and prices. In reaction to the economic downturn, we initiated an aggressive effort to reduce substrate manufacturing costs. This included moving much of our substrate manufacturing operations to China, reducing capacity in our Fremont, CA facility and developing and investing in key low-cost raw material sources.

      In 2003, we believe that the wireless communications and HBLED markets grew, but our revenue did not increase until the fourth quarter of 2003 due to continued reductions in prices and the time required to improve our substrate surface quality and regain some lost customers. Revenue for 2003 fell by $10.2 million, or 22.6% compared with 2002. We recorded losses in each quarter of 2003. During the year we continued to shift more of our manufacturing operations to China and reduced our costs incurred in the United States.

      We cannot predict the level of future industry demand or of our ability to regain lost market share, but they have impacted our ability to sell our products and operate profitably. If demand for our products remains depressed for an extended period, our business will be harmed as a result. Our business performance will be most influenced by market demand for compound semi-conductor substrates, our ability to offer products that equal or exceed the quality provided by competitors, product pricing, our ability to shift more of our manufacturing production to China, and our ability to create and defend our intellectual property while not infringing on the intellectual property of others.

Critical Accounting Policies and Estimates

      We have prepared our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America. As such, we have had to make estimates, assumptions and judgments that affect the amounts reported on our financial statements. These estimates, assumptions and judgments about future events and their effects on our results cannot be determined with certainty, and are made based upon our historical experience and on other assumptions that are believed to be reasonable under the circumstances. These estimates may change as new events occur or additional information is obtained, and we may periodically be faced with uncertainties, the outcomes of which are not within our control and may not be known for a prolonged period of time. The discussion and analysis of our results of operations and financial condition are based upon these consolidated financial statements. We have identified the policies below as critical to our business operations and understanding of our financial condition and results of operations. A critical accounting policy is one that is both material to the presentation of our financial statements and requires us to make difficult, subjective or complex judgments that could have a material effect on our financial condition and results of operations. They may require us to make assumptions about matters that are highly uncertain at the time of the estimate, and different estimates that we could have used, or changes in the estimate that are reasonably likely to occur, may have a material impact on our financial condition or results of operations.

14


Table of Contents

      We believe that the following are our critical accounting policies:

 
Revenue Recognition

      We recognize revenue upon shipment of products to our customers provided that we have received a signed purchase order, the price is fixed or determinable, title has transferred, collection of resulting receivables is probable, product returns are reasonably estimable, there are no customer acceptance requirements and there are no remaining obligations. We assess the probability of collection based on a number of factors including past history with the customer and credit worthiness. We provide for future returns based on historical experience, current economic trends and changes in customer demand at the time revenue is recognized. Except for sales in Japan and some sales in Taiwan, which in both cases are denominated in Japanese yen, we denominate and collect our international sales in U.S. dollars. We do not provide for warranty related exposure as such exposure has historically been immaterial.

 
Allowance for Doubtful Accounts

      We periodically review the likelihood of collecting our accounts receivable balances and provide an allowance for doubtful accounts receivable primarily based upon the age of these accounts. We provide a 100% allowance for U.S. receivables in excess of 90 days and for foreign receivables in excess of 120 days. At December 31, 2003 our accounts receivable balance was $6.3 million net of an allowance for doubtful accounts of $4.3 million.

 
Inventory

      Inventories are stated at the lower of cost or market. Cost is determined using the standard cost method. Finished goods and work-in-process inventories include material, labor and manufacturing overhead costs. We routinely evaluate the levels of our inventory in light of current market conditions in order to identify excess and obsolete inventory and we provide a valuation allowance for certain inventories based upon the age and quality of the product. Competitive delivery times are frequently less than the time required for us to manufacture a product, requiring us to build some work-in-process inventories in anticipation of orders. If orders are not obtained for the product built, the products will ultimately be deemed obsolete and we will establish a reserve for their value. We also review our inventory to ensure costs can be realized upon ultimate sale to our customers. If we determine that the value of any items in ending inventory exceeds the sales value less any related selling costs, a reserve is established for the difference.

 
Impairment of Long-Lived Assets

      We evaluate the recoverability of property, equipment, and intangible assets in accordance with Statement of Financial Accounting Standards No. 144, or SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets.” When events and circumstances indicate that long-lived assets may be impaired, we compare the carrying value of the long-lived assets to the projection of future undiscounted cash flows attributable to such assets and in the event that the carrying value exceeds the future undiscounted cash flows, we record an impairment charge against income equal to the excess of the carrying value over the asset’s fair value.

 
Investments

      We determine the appropriate classification of investments at the time of purchase. Available-for-sale investments are carried at their fair value based on quoted market prices as of the balance sheet date. The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is included in “other (income) and expense, net.” Realized gains or losses are determined on the specific identification method and are reflected in “other (income) and expense, net.” Net unrealized gains or losses are recorded directly in stockholders’ equity. Those unrealized losses that are deemed to be other than temporary are reflected in “interest and other income, net.” We also maintain minority investments in private companies which are accounted for under the cost basis. These investments are reviewed for other

15


Table of Contents

than temporary declines in value on a quarterly basis. Reasons for other than temporary declines in value include whether the related company would have insufficient cash flow to operate for the next twelve months, significant changes in the operating performance and changes in market conditions.
 
Income Taxes

      We account for deferred income taxes using the liability method, under which the expected future tax consequences of timing differences between the book and tax basis of assets and liabilities are recognized as deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce net deferred tax assets when management estimates, based on available objective evidence, that it is more likely than not that the future income tax benefit represented by the net deferred tax asset will not be realized.

Voluntary Stock Option Exchange Program

      On May 27, 2003, we announced a voluntary stock option exchange program for our employees. Under the program, our option holders, excluding our executive officers and independent directors, had the opportunity to cancel outstanding options with an exercise price in excess of $2.10 per share in exchange for new options to be granted at a future date that was at least six months and one day after the cancellation date. The number of shares of common stock subject to the new options was equal to 75% of the number subject to the exchanged options. Under the exchange program, options to purchase an aggregate of 738,027 shares of our common stock, representing approximately 48% of the options that were eligible to be tendered in the Offer were tendered and cancelled. New options will vest at the same rate as the exchanged options and have an exercise price equal to the fair market value of our common stock at the new grant date, which was $3.11 per share. On December 31, 2003, we granted options to purchase an aggregate of 522,754 shares of our common stock in exchange for such tendered options.

16


Table of Contents

Results of Operations

      The following table sets forth certain operating data as a percentage of total revenues for the periods indicated.

                             
Years Ended December 31,

2003 2002 2001



Revenue
    100.0 %     100.0 %     100.0 %
Cost of revenue
    93.6 %     119.8 %     62.0 %
     
     
     
 
Gross profit (loss)
    6.4 %     (19.8 )%     38.0 %
Operating expenses:
                       
 
Selling, general, and administrative
    30.2 %     30.9 %     15.8 %
 
Research and development
    3.9 %     5.2 %     3.6 %
 
Restructuring costs
    0.0 %     32.6 %     0.0 %
     
     
     
 
   
Total operating expenses
    34.1 %     68.7 %     19.4 %
     
     
     
 
Income (loss) from operations
    (27.7 )%     (88.5 )%     18.6 %
Interest expense
    1.3 %     1.0 %     0.8 %
Other (income) and expense, net
    3.0 %     28.3 %     12.3 %
     
     
     
 
Income (loss) from continuing operations before provision for income taxes
    (32.0 )%     (117.8 )%     5.5 %
Provision for income taxes
    0.0 %     4.7 %     2.0 %
     
     
     
 
Income (loss) from continuing operations
    (32.0 )%     (122.5 )%     3.5 %
Discontinued operations:
                       
 
Loss from discontinued operations
    (17.8 )%     (77.1 )%     (12.7 )%
 
Loss on disposal
    (27.3 )%     0.0 %     0.0 %
 
Benefit for income taxes
    0.0 %     18.8 %     4.6 %
     
     
     
 
Loss from discontinued operations
    (45.1 )%     (58.3 )%     (8.1 )%
     
     
     
 
Net Loss
    (77.1 )%     (180.8 )%     (4.6 )%
     
     
     
 

Year Ended December 31, 2003 Compared to Year Ended December 31, 2002

      Revenue from continuing operations. Revenue from continuing operations decreased $10.2 million, or 22.6%, to $34.7 million in 2003 compared to $44.9 million in 2002. Total GaAs substrate revenue decreased $4.6 million, or 13.9%, to $28.3 million in 2003 compared to $32.9 million in 2002. Sales of 5 inch and 6 inch diameter GaAs substrates, which are used exclusively to manufacture electronic devices, decreased $3.4 million, or 38.9%, to $5.4 million in 2003 compared to $8.8 million in 2002. InP substrate revenue decreased $4.4 million, or 68.0%, to $2.1 million in 2003 compared to $6.5 million in 2002. InP substrates are used almost exclusively for telecommunications applications. The decrease in GaAs and InP substrate revenue is due to decreased volume and lower average sales prices as a result of the slowdown in our target markets including telecommunications, high speed electronic devices, and short wavelength lasers, and the introduction of VGF-like substrates from our competitors that caused some customers to purchase substrates from our competitors rather than from us.

      International revenue increased to 65.9% of total revenue from continuing operations in 2003 compared to 43.9% in 2002. The increase was primarily due to a greater share of our GaAs substrates being used in opto-electronics applications and the majority of our customers for these applications being in Asia.

      Gross margin. Gross margin increased to 6.4% of revenue in 2003 compared to negative 19.8% in 2002. The increase was primarily due to reduced costs associated with moving most of our production to China. In addition, we incurred a charge of $9.7 million in 2002 related to the write-down of certain inventory that we concluded was obsolete.

17


Table of Contents

      Selling, general and administrative expenses. Selling, general and administrative expenses decreased $3.4 million, or 24.4%, to $10.5 million in 2003 compared to $13.9 million in 2002. As a percentage of total revenue, selling, general and administrative expenses were 30.2% in 2003 compared to 30.9% in 2002. The decrease in selling, general and administrative expenses is the result of our efforts to adjust costs in line with our current business and of our ability to shift some of these activities to China where our costs are lower.

      Research and development expenses. Research and development expenses decreased $1.0 million or 42.8%, to $1.3 million in 2003 compared to $2.3 million in 2002. As a percentage of total revenue, research and development expenses were 3.9% in 2003 compared to 5.2% in 2002. Although we reduced research and development expenses in 2003 as part of our effort to reduce costs, we believe that continued investment in product development is critical to attaining our strategic objectives of maintaining and increasing our technology leadership, and as a result, we expect research and development expenses to remain at current levels in future periods. Research and development efforts during 2003 were focused primarily on improving the yield and surface quality of our GaAs substrates.

      Interest expense. Interest expense increased $29,000, or 6.6%, to $466,000 in 2003 compared to $437,000 in 2002. By the end of 2003, we had repaid $10.1 million in equipment lease and loan debt which will reduce future interest payments.

      Other income and expense, net. Other expense was $1.1 million in 2003 compared to $12.7 million in 2002. The amount in 2003 includes charges of $2.1 million related to the write-down of investments we hold in two privately held U.S. companies. The amount in 2002 includes non-cash charges of $10.8 million related to the write-down to market value of our investment in Finisar Corporation common stock and $3.1 million to write-down a building held for sale to net realizable value.

      Provision for income taxes. Due to our continuing operating losses and uncertainty regarding future profitability, we recorded a full valuation allowance against our net deferred tax assets of $31.2 million in 2002. During 2003, we continued to record a full valuation allowance against our net deferred tax assets and as a result, our effective tax rate decreased to 0.0% for 2003.

      Loss from discontinued operations. Loss from our discontinued opto-electronics division for the year ended December 31, 2003 was $15.6 million, which included a loss on disposal of $9.5 million and the operating loss from our discontinued opto-electronics division of $6.1 million.

Year Ended December 31, 2002 Compared to Year Ended December 31, 2001

      Revenue from continuing operations. Revenue from continuing operations decreased $63.9 million, or 58.8%, to $44.9 million in 2002 compared to $108.8 million in 2001. Total GaAs substrate revenue decreased $42.5 million, or 56.4%, to $32.9 million in 2002 compared to $75.4 million in 2001. Sales of 5” and 6” diameter GaAs substrates decreased $12.8 million, or 59.2%, to $8.8 million in 2002 compared to $21.6 million in 2001. InP substrate revenue decreased $21.7 million, or 77.0%, to $6.5 million in 2002 compared to $28.2 million in 2001. The decrease in GaAs and InP substrate revenue was due to decreased volume and sales prices as a result of the slowdown in our markets including telecommunications, high speed electronic devices, and short wavelength lasers.

      International revenue decreased to 43.9% of total revenue in 2002 compared to 47.5% of total revenue in 2001.

      Gross margin. Gross margin decreased to negative 19.8% of revenue in 2002 compared to positive 38.0% in 2001. The decrease was primarily due to lower unit sales and average sales prices of GaAs and InP substrates spread over a relatively fixed manufacturing overhead base and a $9.7 million charge to write-down excess inventory. As a result, we initiated manufacturing cost reductions in order to align our costs with lower expected sales volumes and prices. We shifted much of our substrate manufacturing to China and reduced capacity in our Fremont, California facility.

      Selling, general and administrative expenses. Selling, general and administrative expenses decreased $3.3 million, or 19.5%, to $13.8 million in 2002 compared to $17.2 million in 2001. As a percentage of total

18


Table of Contents

revenue, selling, general and administrative expenses were 30.9% in 2002 compared to 15.8% in 2001. In order to align our cost structure with the rapid decline in revenues, we initiated and aggressively pursued cost reductions in this area, which led to the decrease in 2002.

      Research and development expenses. Research and development expenses decreased $1.5 million or 39.7%, to $2.3 million in 2002 compared to $3.9 million in 2001. As a percentage of total revenue, research and development expenses were 5.2% in 2002 compared to 3.6% in 2001. Research and development efforts during 2002 were focused primarily on improving the yield and surface quality of our GaAs substrates.

      Interest expense. Interest expense decreased $394,000, or 47.4%, to $437,000 in 2002 compared to $831,000 in 2001. The decrease was primarily due to the repayment of certain long-term real estate notes and capital equipment leases.

      Other income and expense. Other expense was $12.7 million in 2002 compared to $13.4 million in 2001. The amount in 2002 includes non-cash charges of $10.8 million related to the write-down to market value of our investment in Finisar Corporation common stock and $3.1 million to write-down a building held for sale to net realizable value. The 2001 balance includes a non-cash charge of $15.6 million to write-down to market value our investment in Finisar common stock.

      Provision for income taxes. Due to our continuing operating losses during 2002 and uncertainty regarding future profitability, we recorded a full valuation allowance against our net deferred tax assets of $31.2 million in 2002. As a result, our effective tax rate decreased to 7.2% in 2002. Our effective tax rate in 2001 was 36%.

      Loss from discontinued operations. Loss from our discontinued opto-electronics division for the year ended December 31, 2002 was $26.2 million net of income tax benefit of $8.4 million.

Liquidity and Capital Resources

      We consider cash and cash equivalents, and short-term investments as liquid and available for use. Short-term investments are comprised of government bonds and high-grade commercial debt instruments. Also included in short-term investments is our common stock investment in Finisar Corporation.

      Cash and cash equivalents, short-term investments and long-term investments, excluding $3.7 million and $1.1 million for our investment in Finisar common stock at December 31, 2003 and 2002 respectively, increased $8.9 million to $44.6 million at December 31, 2003 compared to $35.7 million at December 31, 2002.

      Cash and cash equivalents increased $10.5 million to $24.3 million at December 31, 2003 compared to $13.8 million at December 31, 2002.

      Net cash provided by operating activities of $6.3 million for the year ended December 31, 2003 was comprised primarily of our net loss adjusted for non-cash items of $18.0 million, consisting primarily of the loss on disposal of our opto-electronics division of $9.5 million, depreciation of $5.8 million, and by a $15.0 million net change in assets and liabilities. The net change in assets and liabilities resulted primarily from a decrease in inventory, prepaid expenses and income tax receivable, offset by decreases in accounts payable and accrued liabilities.

      Accounts receivable decreased $898,000, or 12.5%, to $6.3 million at December 31, 2003 compared to $7.2 million at December 31, 2002. The change reflects lower sales volume, collections of $32.5 million and a decrease in our allowance for doubtful accounts of $2.4 million due to the collection of previously written-down receivables. It also included a $666,000 write-down of accounts receivable from our discontinued opto-electronics division, which is included in “loss on disposal” in our consolidated statement of operations for the year ended December 31, 2003.

      Inventories decreased $13.5 million, or 35.9% to $24.1 million at December 31, 2003 compared to $37.6 million at December 31, 2002. The decrease in inventory included a $2 million write-down of inventory from our discontinued opto-electronics division, which is included in “loss on disposal” in our consolidated

19


Table of Contents

statement of operations for the year ended December 31, 2003. The Company adopted a strategy of using inventory to conserve cash. During 2004 we do not expect to maintain the same rate of net inventory decrease as we experienced in 2003.

      Net cash provided by investing activities of $13.7 million for the year ended December 31, 2003 includes proceeds from the sale of property and equipment, and high grade investment securities totaling $27.7 million, offset by purchases of property and equipment of $2.2 million primarily used to transfer production capacity to China for the substrate division, and purchases of high grade investment securities with maturities of less than two years totaling $5.9 million. It also includes an increase in restricted cash of $5.8 million to collateralize a letter of credit with a bank that supports our long-term debt and workers’ compensation insurance policy.

      We do not have any plans to initiate any major new capital spending projects through 2004. We are currently completing certain projects at our China facilities and are continuously constructing minor improvements to our existing production facilities in China and California. We expect to invest approximately $5.0 million in capital projects in 2004. We believe that our existing and planned facilities and equipment are sufficient to fulfill current and expected future orders.

      Net cash used in financing activities of $9.6 million consisted of proceeds of $480,000 from the exercise of options by our employees, offset by payments of $10.1 million to reduce long-term borrowings and capital leases.

      Our main Fremont, California manufacturing facility is financed by long-term borrowings, which were refinanced by taxable variable rate revenue bonds in 1998. These bonds mature in 2023 and bear interest at a variable rate that was 1.35% at December 31, 2003. The bonds are traded in the public market. Repayment of principal and interest under the bonds is supported by a letter of credit from our bank and is paid on a quarterly basis. We have the option to redeem the bonds in whole or in part during their term. At December 31, 2003, $8.5 million was outstanding under these bonds.

      At December 31, 2003 the credit facility maintained by us with a bank included a letter of credit supporting repayment of our industrial bonds with an outstanding amount of $8.5 million. The Company has pledged and placed cash and certain investment securities with an affiliate of the bank as additional collateral for this facility. We have also pledged cash for a credit facility for our workers compensation insurance. As a result, $9.3 million of our cash and long-term investments are restricted.

      We currently hold a note payable secured by certain equipment in China totaling $3.3 million at December 31, 2003 (see Note 4 to our consolidated financial statements). The balance on this note will be due in December 2004.

      We believe that we have adequate cash and investments to meet the Company’s short- and long-term needs. If our sales decrease, however, our ability to generate cash from operations will be adversely affected which could adversely affect our future liquidity, require us to use more cash at a more rapid rate than expected, and require us to seek additional capital. There can be no assurance that such additional capital will be available or, if available it will be at terms acceptable to the Company. Cash from operations could be affected by various risks and uncertainties, including, but not limited to those set forth below under “Risks Related to Our Business.”

20


Table of Contents

      Outstanding contractual obligations as of December 31, 2003 are summarized below (in thousands):

                         
Operating
Debt Leases Total



2004
  $ 3,694     $ 1,231     $ 4,925  
2005
    514       1,115       1,629  
2006
    459       836       1,295  
2007
    462       616       1,078  
2008
    466       617       1,083  
Thereafter
    6,941       3,236       10,177  
     
     
     
 
    $ 12,536     $ 7,651     $ 20,187  
     
     
     
 

      We lease certain office space, manufacturing facilities and property under long-term operating leases expiring at various dates through March 2013. Total rent expense under these operating leases was approximately $1.2 million for the year ended December 31, 2003, $947,000 in 2002 and $779,000 in 2001.

Risks Related to Our Business

 
The semiconductor industry is cyclical and has experienced a downturn which has adversely impacted our operating results.

      Our continuing business depends in significant part upon manufacturers of electronic and opto-electronic semiconductor devices, as well as the current and anticipated market demand for such devices and products using such devices. As a supplier to the semiconductor industry, we are subject to the business cycles that characterize the industry. The timing, length and volatility of these cycles are difficult to predict. The semiconductor industry has historically been cyclical because of sudden changes in demand for semiconductors and capacity requirements, including capacity utilizing the latest technology. The rate of changes in demand, including end demand, is high, and the effect of these changes upon us occurs quickly, exacerbating the volatility of these cycles. These changes have affected the timing and amounts of customers’ capital equipment purchases and investments in new technology. These industry cycles create pressure on our net sales, gross margin and net income.

      The industry has previously experienced periods of oversupply that result in significantly reduced demand for semiconductor devices and components, including our products, both as a result of general economic changes and overcapacity. When these periods occur, our operating results and financial condition are adversely affected, and create pressure on our revenue, gross margins and net income. Inventory buildups in telecommunications products and slower than expected sales of computer equipment resulted in overcapacity and led to reduced sales by our customers, and therefore reduced purchases of our products. During periods of weak demand such as those experienced over the past years, customers typically reduce purchases, delay delivery of products and/or cancel orders of component parts such as our products. Increased price competition has resulted, causing pressure on our net sales, gross margin and net income. We experienced cancellations, price reductions, delays and push outs of orders, which have resulted in reduced revenues. If the economic downturn were to continue, or occur again in the future, further order cancellations, reductions in order size or delays in orders will materially adversely affect our business and results of operations. Actions to reduce our costs, such as those we have recently taken, may be insufficient to align our structure with prevailing business conditions. We may be required to undertake additional cost-cutting measures, and may be unable to invest in marketing, research and development and engineering at the levels we believe are necessary to maintain our competitive position. Our failure to make these investments could seriously harm our business.

      During periods of increasing demand for semiconductor devices, we must have sufficient manufacturing capacity and inventory to meet customer demand, and must be able to attract, hire, train and retain qualified employees to meet demand. It appears that the semiconductor industry is in the early stages of an upturn and increasing demand. However, we cannot predict the sustainability of a recovery, if any, and the industry’s rate of growth in this recovery, if it occurs. If we are unable to effectively manage our resources and production

21


Table of Contents

capacity during an industry upturn, there could be a material adverse effect on our business, financial condition and results of operations.
 
If the economy recovers and we are again in a period of high demand for our products, we may be unable to expand our manufacturing capacity quickly enough to meet increased demand, we may make decisions to expand capacity that are not profitable, and we may be unable to lower our costs or increase revenue.

      It appears that the industry may be in an upturn, which may cause demand to increase rapidly as it has in prior years after other cyclical downturns in the economy and the industries in which we operate. If this happens, in order to meet increased demand and maintain our market share, we may need to increase production, which could require us to build new facilities, expand and modify our existing facilities, purchase additional manufacturing equipment, and add qualified staff. If we are not at that time able to expand our manufacturing capacity, we will be unable to increase production, which may adversely impact our ability to meet increased production demand while reducing unit costs, margins and improving our operating results.

We are currently constructing and modifying facilities in California and China. Our construction activities subject us to a number of risks, including:

  •  unforeseen environmental or engineering problems;
 
  •  unavailability or late delivery of production equipment;
 
  •  delays in completing new facilities;
 
  •  delays in bringing production equipment on-line;
 
  •  work stoppages or delays;
 
  •  inability to recruit and train qualified staff; and
 
  •  unanticipated cost increases and restrictions imposed by requirements of local, state or federal regulatory agencies in the United States and China.

      If any of these risks occurs, construction may be costlier than anticipated and completion could be delayed, which could hurt our ability to expand capacity and increase our sales. In addition, if we experience delays in expanding our manufacturing capacity, we may not be able to timely meet customer requirements, and we could lose future sales. We are also completing selective investments in equipment and facilities as part of our previously planned capacity expansion. To offset the additional fixed operating expenses, we must increase our revenue by increasing production and improving yields. If demand for our products does not grow, if prices decline significantly, or if our yields do not improve as anticipated, we may be unable to offset these costs against increased revenue, which would adversely impact our operating results.

 
Unpredictable fluctuations in our operating results could disappoint analysts or our investors, which could cause our stock price to decline.

      We have not over the past year been able to sustain growth, and may not be able to return to historic growth levels in the current economic environment. Our net loss in 2002 was the largest in our history and our losses continued during 2003. We believe we will endure losses for at least part of 2004. We have and may continue to experience significant fluctuations in our revenue and earnings. Our quarterly and annual revenue and operating results have varied significantly in the past and may vary significantly in the future due to a number of factors, including:

  •  decline in general economic conditions or downturns in the industry in which we compete;
 
  •  fluctuations in demand for our products;
 
  •  expansion of our manufacturing capacity;
 
  •  expansion of our operations in China;

22


Table of Contents

  •  limited availability and increased cost of raw materials;
 
  •  the volume and timing of orders from our customers, and cancellations, push outs and delays of customer orders;
 
  •  fluctuation of our manufacturing yields;
 
  •  decreases in the prices of our competitors’ products;
 
  •  costs incurred in connection with any future acquisitions of businesses or technologies;
 
  •  increases in our expenses, including expenses for research and development; and
 
  •  our ability to develop, manufacture and deliver high quality products in a timely and cost-effective manner.

      Due to these factors, we believe that period-to-period comparisons of our operating results may not be meaningful indicators of our future performance. Our operating results have over the past year at times been below the expectations of securities analysts or investors. If this occurs again in future periods, the price of our common stock could decline or fluctuate.

      A substantial percentage of our operating expenses are fixed in the short term and we may be unable to adjust spending to compensate for an unexpected shortfall in revenues. As a result, any delay in generating revenue could cause our operating results to be below the expectations of market analysts or investors, which could also cause our stock price to fall.

 
      Our results of operations may suffer if we do not effectively manage our inventory.

      We must manage our inventory of component parts, work-in-process, and finished goods effectively to meet changing customer requirements, while keeping inventory costs down and improving gross margins. Some of our products and supplies have in the past and may in the future become obsolete while in inventory due to changing customer specifications, or become excess inventory due to decreased demand for our products and an inability to sell the inventory within a foreseeable period. Furthermore, if current costs of production increase or sales prices drop below the standard prices at which we value inventory, we may need to take a charge for a reduction in inventory values. We have in the past had to take inventory valuation and impairment charges. If we are not successfully able to manage our inventory, we may need to write off unsaleable, obsolete or excess inventory, which could adversely affect our results of operations. On October 1, 2003, we implemented a new inventory control system that may experience unexpected difficulties.

 
      The disposal of our opto-electronics business may fail to result in the benefits we anticipate.

      We may not obtain the benefits we expect as a result of discontinuation of our opto-electronics business, such as greater strategic focus on our core businesses. We may be required to return to the buyer some or all of the $1 million of the sale proceeds which will be held in escrow should the buyer successfully claim that we breached one of the representations or warranties made to it. Our building in Monterey Park may not be sold for the $1 million at which we are carrying it on our balance sheet. We may incur additional costs associated with the discontinued operations which could materially reduce our short term earnings.

 
      Much of our cash resources are denominated in Chinese currency and are subject to exchange control restrictions.

      Much of our cash resources are denominated in Chinese Renminbi and held in accounts in China and, under some circumstances, may not be easily exchanged for US dollars. The value of our Chinese cash holdings are also subject to changes in the exchange rate between Chinese Renminbi and US dollars. If our US dollar commitments were to exceed the cash we have available in the United States, we may be unable to access cash held in China to satisfy these commitments.

23


Table of Contents

 
      A reoccurrence of Severe Acute Respiratory Syndrome (SARS) or the outbreak of a different contagious disease may adversely impact our manufacturing operations and some of our key suppliers and customers.

      The majority of our substrate manufacturing activities are conducted in China. In addition, we source key raw materials, including gallium, from our joint ventures and other suppliers in China. The 2003 SARS outbreak was most notable in China and a small number of cases have been reported to date in 2004. One employee at our LED production facility in China contracted SARS in late April 2003 prompting us to close the facility for ten days. There was no significant impact to our ability to fill customer orders. If there were to be another outbreak of SARS or a different contagious disease and if our employees contracted the disease, we may be required to temporarily close our manufacturing operations. Similarly, if one of our key suppliers is required to close for an extended period, we may not have enough raw material inventory to continue manufacturing operations. In addition, while we possess management skills among our China staff that enable us to maintain our manufacturing operations with minimal on-site supervision from our US-based staff, our business could also be harmed if travel to or from Asia and the United States is restricted or inadvisable, as it was during parts of 2003. None of our substrate competitors is as dependent on manufacturing facilities in China as we are. If our manufacturing operations were closed for a significant period, we could lose revenue and market share during that period which would depress our financial performance and could be difficult to recapture. Finally, if one of our key customers is required to close for an extended period, we may not be able to ship product to them, our revenue would decline and our financial performance would suffer.

 
      The impact of changes in global economic conditions on our customers may cause us to fail to meet expectations, which would negatively impact the price of our stock.

      Our operating results can vary significantly based upon the impact of changes in global economic conditions on our customers. More specifically, the macro-economic environment that we faced in 2003 was more uncertain than in some prior periods, lasted longer than expected and has materially and adversely affected us and our operating results and may continue to do so. The revenue growth and profitability of our business depends on the overall demand for our substrates, and we are particularly dependant on the market conditions for the wireless, solid-state illumination, fiber optics and telecommunications industries. Because our sales are primarily to major corporate customers whose businesses fluctuate with general economic and business conditions, a softening of demand for products that use our substrates, caused by a weakening economy may result in further or prolonged decreased revenues. Customers may find themselves facing excess inventory from earlier purchases, and may defer or reconsider purchasing products due to the downturn in their business and in the general economy.

 
      If we do not successfully develop new products to respond to rapidly changing customer requirements, our ability to generate sales and obtain new customers may suffer.

      Our success depends on our ability to offer new products and product features that incorporate leading technology and respond to technological advances. In addition, our new products must meet customer needs and compete effectively on quality, price and performance. The life cycles of our products are difficult to predict because the markets for our products are characterized by rapid technological change, changing customer needs and evolving industry standards. If our competitors introduce products employing new technologies or performance characteristics, our existing products could become obsolete and unmarketable. During the past year, we have seen our competitors selling more substrates manufactured using a crystal growth technology similar to ours, which has eroded our technological differentiation. If we fail to offer new products, we may not generate sufficient revenue to offset our development costs and other expenses or meet our customers’ requirements. Other companies, including Triquent, are actively developing substrate materials that could be used to manufacture devices that could provide the same high-performance, low-power capabilities as GaAs- and InP-based devices at competitive prices. If these substrate materials or VGF derived products are successfully developed and semiconductor device manufacturers adopt them, demand for our GaAs substrates could decline and our revenue could suffer.

24


Table of Contents

      The development of new products can be a highly complex process, and we may experience delays in developing and introducing new products. Any significant delays could cause us to fail to timely introduce and gain market acceptance of new products. Further, the costs involved in researching, developing and engineering new products could be greater than anticipated.

 
      Our operating results depend in large part on further customer acceptance of our existing substrate products manufactured in China.

      To shift more of our substrate manufacturing operations to China successfully, we will need our customers to qualify products manufactured in China. If we are unable to achieve qualifications for these products, our China facility will be underutilized, our investments in China will not be recouped and we will be unable to lower our costs by moving to China. We may lose sales of our products to competitors who are not manufacturing in China, or whose operations in China have already been qualified by customers. All of these events could reduce our revenue but increase our cost structure.

      Furthermore, some customers have reduced their orders from us until our surface quality is as good and consistent as that offered by competitors. As a result, some customers are now allocating their requirements for VGF grown substrates across more competitors and we believe that we have lost revenue and market share as a result of these customer decisions, which we may be unable to recover. If we are unable to retain our market share, our revenue and performance will decline.

 
      Intense competition in the markets for our products could prevent us from increasing revenue and sustaining profitability.

      The markets for our products are intensely competitive. We face competition for our substrate products from other manufacturers of substrates, such as Freiberger, Hitachi Cable, Japan Energy and Sumitomo Electric and from semiconductor device manufacturers that produce substrates for their own use, and from companies, such as Triquent, that are actively developing alternative materials to GaAs and some semiconductor devices are being marketed using these materials. We believe that at least two of our competitors are shipping high volumes of GaAs substrates manufactured using a technique similar to our VGF technique. Other competitors may develop and begin using similar technology. If we are unable to compete effectively, our revenue may not increase and we may be unable to be profitable. We face many competitors that have a number of significant advantages over us, including:

  •  greater experience in the business;
 
  •  more manufacturing experience;
 
  •  extensive intellectual property;
 
  •  broader name recognition; and
 
  •  significantly greater financial, technical and marketing resources.

      Our competitors could develop new or enhanced products that are more effective than our products are.

      The level and intensity of competition has increased over the past year and we expect competition to continue to increase in the future. Competitive pressures caused by the current economic conditions have resulted in reductions in the prices of our products, and continued or increased competition could reduce our market share, require us to further reduce the prices of our products, affect our ability to recover costs or result in reduced gross margins.

 
      Defects in our products could diminish demand for our products.

      Our products are complex and may contain defects. We have experienced quality control problems with some of our products over the past two years, which caused customers to return products to us, reduce orders for our products, or both. If we continue to experience quality control problems, or experience these or other problems in new products, customers may cancel or reduce orders or purchase products from our competitors

25


Table of Contents

and sales of our products could decline. Defects in our products could cause us to incur higher manufacturing costs and suffer product returns and additional service expenses, all of which could adversely impact our operating results.

      If new products developed by us contain defects when released, our customers may be dissatisfied and we may suffer negative publicity or customer claims against us, lose sales or experience delays in market acceptance of our new products.

 
      If we have low product yields, the shipment of our products may be delayed and our operating results may be adversely impacted.

      Our products are manufactured using complex technologies, and the number of usable substrates we can produce can fluctuate as a result of many factors, including:

  •  impurities in the materials used;
 
  •  contamination of the manufacturing environment;
 
  •  substrate breakage;
 
  •  equipment failure, power outages or variations in the manufacturing process; and
 
  •  performance of personnel involved in the manufacturing process.

      If our yields decrease, our revenue could decline because many of our manufacturing costs are fixed, or would increase. We have experienced product shipment delays and difficulties in achieving acceptable yields on both new and older products, and delays and poor yields have adversely affected our operating results. We may experience similar problems in the future and we cannot predict when they may occur or their severity. In particular, many of our manufacturing processes are new and are still being refined, which can result in lower yields.

 
      We derive a significant portion of our revenue from international sales, and our ability to sustain and increase our international sales involves significant risks.

      Our revenue growth depends in part on the expansion of our international sales and operations. International sales represented 65.9% of our total revenue for the year ended December 31, 2003 and 43.9% for the year ended December 31, 2002. We expect that sales to customers outside the U.S. will continue to represent a significant portion of our revenue, particularly sales to customers in Asia.

      Currently, an increasing percentage of our sales are to customers headquartered in Asia. Certain manufacturing facilities and suppliers are also located outside the U.S. Managing our global operations presents challenges, including periodic regional economic downturns, trade balance issues, varying business conditions and demands, political instability, variations in enforcement of intellectual property and contract rights in different jurisdictions, differences in the ability to develop relationships with suppliers and other local businesses, changes in U.S. and international laws and regulations including U.S. export restrictions, fluctuations in interest and currency exchange rates, the ability to provide sufficient levels of technical support in different locations, cultural differences, shipping delays and terrorist acts or acts of war, among other risks. Many of these challenges are present in China, which represents a large potential market for semiconductor equipment and where AXT anticipates significant opportunity for growth. Global uncertainties with respect to: (i) economic growth rates in various countries; (ii) sustainability of demand for electronics products; (iii) capital spending by semiconductor manufacturers; (iv) price weakness for certain semiconductor devices; and (v) political instability in regions where we have operations may also affect our business, financial condition and results of operations.

      Our dependence on international sales involves a number of risks, including:

  •  changes in tariffs, import or export restrictions and other trade barriers;
 
  •  unexpected changes in regulatory requirements;

26


Table of Contents

  •  longer periods to collect accounts receivable;
 
  •  changes in export license requirements;
 
  •  political and economic instability;
 
  •  unexpected changes in diplomatic and trade relationships; and
 
  •  foreign exchange rate fluctuations.

      Our sales are denominated in U.S. dollars, except for sales to our Japanese and some Taiwanese customers, which are denominated in Japanese yen. Thus, increases in the value of the U.S. dollar could increase the price of our products in non-U.S. markets and make our products more expensive than competitors’ products in these markets. Also, denominating some sales in Japanese yen subjects us to fluctuations in the exchange rates between the U.S. dollar and the Japanese yen. The functional currencies of our Japanese and Chinese subsidiaries are the local currencies. We incur transaction gains or losses resulting from consolidation of expenses incurred in local currencies for these subsidiaries, as well as in translation of the assets and liabilities of these assets at each balance sheet date. If we do not effectively manage the risks associated with international sales, our revenue, cash flows and financial condition could be adversely affected.

 
      Demand for our products may decrease if our customers experience difficulty manufacturing, marketing or selling their products.

      Our products are used as components in our customers’ products. Accordingly, demand for our products is subject to factors affecting the ability of our customers to successfully introduce and market their products, including:

  •  the competition our customers face in their particular industries;
 
  •  the technical, manufacturing, sales and marketing and management capabilities of our customers;
 
  •  the financial and other resources of our customers; and
 
  •  the inability of our customers to sell their products if they infringe third party intellectual property rights.

      If demand for the end user applications for which our products are used decreases, or our customers are unable to develop, market and sell their products, demand for our products will decrease.

 
      The financial condition of our customers may affect their ability to pay amounts owed to us.

      Many of our customers are facing business downturns that have reduced their cash balances and their prospects. We frequently allow our customers to pay for products we ship to them within 30 to 90 days after delivery. Subsequent to our shipping a product, some customers have been unable to make payments as due, reducing our cash balances and causing us to incur charges to allow for a possibility that some accounts might not be paid. At least three customers that owed us a significant amount have filed for bankruptcy protection and we are unlikely to receive a substantial portion or any of the amounts owed to us as part of a bankruptcy settlement. Other customers may also be forced to file for bankruptcy. If our customers do not pay their accounts when due, we will be required to incur charges that would reduce our earnings.

 
      We purchase critical raw materials and parts for our equipment from single or limited sources, and could lose sales if these sources fail to fill our needs.

      We depend on a limited number of suppliers for certain raw materials, components and equipment used in manufacturing our products, including key materials such as quartz tubing, polishing solutions, and paralytic boron nitride. We generally purchase these materials through standard purchase orders and not pursuant to long-term supply contracts and no supplier guarantees supply of raw materials or equipment to us. If we lose any of our key suppliers, our manufacturing efforts could be significantly hampered and we could be prevented from timely producing and delivering products to our customers. We have experienced delays

27


Table of Contents

obtaining critical raw materials and spare parts, including gallium, due to shortages of these materials. We may experience delays due to shortages of materials and may be unable to obtain an adequate supply of materials. These shortages and delays could result in higher materials costs and cause us to delay or reduce production of our products. If we have to delay or reduce production, we could fail to meet customer delivery schedules and our revenue and operating results could suffer.

If we fail to comply with environmental and safety regulations, we may be subject to significant fines or cessation of our operations; in addition, we could be subject to suits for personal injuries caused by exposure to hazardous materials.

      We are subject to federal, state and local environmental and safety laws and regulations in all of our operating locations. These laws, rules and regulations govern the use, storage, discharge and disposal of hazardous chemicals during manufacturing, research and development, and sales demonstrations. If we fail to comply with applicable regulations, we could be subject to substantial liability for clean-up efforts, personal injury and fines or suspension or cessation of our operations. In March 2001, we settled a claim made by the California Occupational Safety and Health Administration, or Cal-OSHA, in an investigation primarily regarding impermissible levels of potentially hazardous materials in certain areas of our manufacturing facility in Fremont, California for $200,415. Although we have put in place engineering, administrative and personnel protective equipment programs to address these issues, our ability to expand or continue to operate our present locations could be restricted or we could be required to acquire costly remediation equipment or incur other significant expenses. Existing or future changes in laws or regulations may require us to incur significant expenditures or liabilities, or may restrict our operations. In addition, our employees could be exposed to chemicals or other hazardous materials at our facilities and we may be subject to lawsuits seeking damages for wrongful death or personal injuries allegedly caused by exposure to chemicals or hazardous materials at our facilities.

      If litigation is brought against us, litigation is inherently uncertain and while we would expect to defend ourself vigorously, it is possible that our business, financial condition, results of operations or cash flows, could be affected in any particular period by such litigation if brought against us.

 
      The loss of one or more of our key substrate customers would significantly hurt our operating results.

      A small number of substrate customers have historically accounted for a substantial portion of our total revenue. Five customers accounted for 28.9% of our total revenue for the year ended December 31, 2003 and 31.4% for the year ended December 31, 2002. One customer accounted for 6.8% of our revenue for the year ended December 31, 2003. We expect that a significant portion of our future revenue will continue to be derived from a limited number of substrate customers. Our customers are not obligated to purchase a specified quantity of our products or to provide us with binding forecasts of product purchases. In addition, our customers may reduce, delay or cancel orders at any time without any significant penalty, and during the past year, we have experienced slower bookings, significant push outs and cancellation of orders. In addition, due to the difficult economic environment, several of our previously large customers have stopped operations entirely. If we lose a major customer or if a customer cancels, reduces or delays orders, our revenue would decline. In addition, customers that have accounted for significant revenue in the past may not continue to generate revenue for us in any future period. Any delay in scheduled shipments of our products could cause net sales to fall below our expectations and the expectations of market analysts or investors, causing our stock price to decline.

 
      Our substrate products have a long qualification cycle that makes it difficult to plan our expenses and forecast our results.

      Customers typically place orders with us for our substrate products three months to a year or more after our initial contact with them. The sale of our products may be subject to delays due to our customers’ lengthy internal budgeting, approval and evaluation processes. During this time, we may incur substantial expenses and expend sales, marketing and management efforts while the customers evaluate our products. These expenditures may not result in sales of our products. If we do not achieve anticipated sales in a period as

28


Table of Contents

expected, we may experience an unplanned shortfall in our revenue. As a result, we may not be able to cover expenses, causing our operating results to vary. In addition, if a customer decides not to incorporate our products into its initial design, we may not have another opportunity to sell products to this customer for many months or even years. In the current competitive and economic climate, the average sales cycle for our products has lengthened even further and is expected to continue to make it difficult to accurately forecast our future sales. We anticipate that sales of any future substrate products will also have lengthy sales cycles and will, therefore, be subject to risks substantially similar to those inherent in the lengthy sales cycle of our current substrate products.
 
      If we are unable to protect our intellectual property, we may lose valuable assets or incur costly litigation.

      We rely on a combination of patents, copyrights, trademark and trade secret laws, non-disclosure agreements and other intellectual property protection methods to protect our proprietary technology. However, we believe that, due to the rapid pace of technological innovation in the markets for our products, our ability to establish and maintain a position of technology leadership also depends on the skills of our development personnel.

      Despite our efforts to protect our intellectual property, a third party could develop products or processes similar to ours. Our means of protecting our proprietary rights may not be adequate and our competitors may independently develop similar technology, duplicate our products or design around our patents. We believe that at least two of our competitors have begun to ship GaAs substrates produced using a process similar to our VGF technique. Our competitors may also develop and patent improvements to the VGF technology upon which we rely, and thus may limit any exclusivity we enjoy by virtue of our patents or trade secrets.

      It is possible that pending or future United States or foreign patent applications made by us will not be approved, that our issued patents will not protect our intellectual property, or that third parties will challenge the ownership rights or the validity of our patents. In addition, the laws of some foreign countries may not protect our proprietary rights to as great an extent as do the laws of the United States and it may be more difficult to monitor the use of our intellectual property. Our competitors may be able to legitimately ascertain non-patented proprietary technology embedded in our systems. If this occurs, we may not be able to prevent the development of technology substantially similar to ours.

      We may have to resort to costly litigation to enforce our intellectual property rights, to protect our trade secrets or know-how or to determine their scope, validity or enforceability. Enforcing or defending our proprietary technology is expensive, could cause us to divert resources and may not prove successful. Our protective measures may prove inadequate to protect our proprietary rights, and if we fail to enforce or protect our rights, we could lose valuable assets.

 
      Intellectual property infringement claims may be costly to resolve and could divert management attention.

      Other companies may hold or obtain patents on inventions or may otherwise claim proprietary rights to technology necessary to our business. The markets in which we compete are comprised of competitors who in some cases hold substantial patent portfolios covering aspects of products that could be similar to ours. We could become subject to claims that we are infringing patent, trademark, copyright or other proprietary rights of others, and have recently been sued by a substrate competitor concerning alleged patent infringement. Litigation to determine the validity of alleged claims could be time-consuming and result in significant expense to us and divert the efforts of our technical and management personnel, whether or not the litigation is ultimately determined in our favor. If a lawsuit is decided against us, we could be subject to significant liabilities, requiring us to seek costly licenses or preventing us from manufacturing and selling our products. We may not be able to obtain required licensing agreements on terms acceptable to us or at all.

29


Table of Contents

 
      As our business matures, we may need to upgrade our systems, or incur additional costs related to regulatory compliance.

      In the past, periods of rapid growth and expansion has strained our management and other resources. The expansion of our manufacturing capacity and the shift of manufacturing operations to China placed and continue to place a significant strain on our operations and management resources. We recently upgraded our inventory control systems and may implement additional systems relating to consolidation of our financial results. If we fail to manage these changes effectively, our operations may be disrupted.

      To manage our business effectively, we may need to implement additional and improved management information systems, further develop our operating, administrative, financial and accounting systems and controls, add experienced senior level managers, and maintain close coordination among our executive, engineering, accounting, marketing, sales and operations organizations.

      If necessary, we will spend substantial sums to support our future growth and shift to China and to comply with the reporting and attestation requirements of the Sarbanes-Oxley Act of 2002. We may incur additional unexpected costs. Our systems, procedures or controls may not be adequate to support our operations, and we may be unable to expand quickly enough to exploit potential market opportunities.

 
      If we fail to manage periodic contractions, we may utilize our cash balances and our existing cash and cash equivalent balances could decline.

      We anticipate that our existing cash resources will fund any anticipated operating losses, purchases of capital equipment and provide adequate working capital for the next twelve months. However, our liquidity is affected by many factors including, among others, the extent to which we pursue additional capital expenditures, the level of our production, and other factors related to the uncertainties of the industry and global economies. If we fail to manage our contractions successfully we may draw down our cash reserves, which would adversely affect our operating results and financial condition, reduce our value and may impinge our ability to raise debt and equity funding in the future, at a time when we may be required to raise additional cash. Accordingly, there can be no assurance that events in the future will not require us to seek additional capital, or, if so required, that such capital will be available on terms acceptable to us, if at all. As part of our effort to reduce costs, we may lose key staff, production resources, and technology that we will need to grow when end markets recover. These events could reduce our ability to grow profitably as markets recover.

 
      As a result of the difficult economic conditions, we have implemented restructuring and workforce reductions, which may adversely affect the morale and performance of our personnel and our ability to hire new personnel.

      In connection with our efforts to streamline operations, reduce costs and bring staffing and structure in line with demand for our products, we implemented a corporate restructuring beginning in 2001 and reduced our workforce, shifted production activities to China, reduced capital expenditures, and discontinued our opto-electronics business. In addition, our stock price is volatile, which can affect the value of stock options issued to our employees. Our restructuring may yield unanticipated consequences, such as attrition beyond our planned reduction in workforce and loss of employee morale and decreased performance. As a result of these factors, our remaining personnel may seek employment with larger, more established companies or companies that they perceive as having less volatile stock prices. Continuity of personnel can be very important factors in the sales and production of our products and completion of our research and development efforts.

30


Table of Contents

 
      Any future acquisitions may disrupt our business, dilute stockholder value or distract management attention.

      As part of our strategy, we may consider acquisitions of, or significant investments in, businesses that offer products, services and technologies complementary to ours. Acquisitions entail numerous risks, including:

  •  we may have difficulty assimilating the operations, products and personnel of the acquired businesses;
 
  •  our ongoing business may be disrupted;
 
  •  we may incur unanticipated costs;
 
  •  our management may be unable to manage the financial and strategic position of acquired or developed products, services and technologies;
 
  •  we may be unable to maintain uniform standards, controls, procedures, and policies; and
 
  •  our relationships with employees and customers may be impaired as a result of any integration.

      For example, we incurred substantial costs in connection with our acquisition of Lyte Optronics in May 1999, including the assumption of approximately $10.0 million of debt, which was subsequently repaid, resulting in a decline of cash available. We also incurred consistent operating losses for the business following the acquisition, and have discontinued all operations and sold the related assets acquired in our acquisition of Lyte Optronics during 2003.

      To the extent that we issue shares of our stock or other rights to purchase stock in connection with any future acquisitions, dilution to our existing stockholders will result and our earnings per share may suffer. Any future acquisitions may not generate additional revenue or provide any benefit to our business.

 
      If any of our facilities is damaged by actions such as fire, explosion, or natural disaster, we may not be able to manufacture our products.

      The ongoing operation of our manufacturing and production facilities in California and China is critical to our ability to meet demand for our products. If we are not able to use all or a significant portion of our facilities for prolonged periods for any reason, we will not be able to manufacture products for our customers. For example, a natural disaster, fire or explosion caused by our use of combustible chemicals and high temperatures during our manufacturing processes would render some or all of our facilities inoperable for an indefinite period of time. Actions outside of our control, such as earthquakes, could also damage our facilities, rendering them inoperable. Some of our manufacturing and research and development is currently performed at our Fremont, California facilities, which are located near an active seismic fault line. If we are unable to operate our facilities and manufacture our products, we will lose customers and revenue and our business will be harmed.

 
      If we lose key personnel or are unable to hire additional qualified personnel as necessary, we may not be able to successfully manage our business or achieve our objectives.

      Our success depends upon the continued service of Morris S. Young, Ph.D., our president, chairman of the board and chief executive officer, as well as other key management and technical personnel. We do not have long-term employment contracts with, or key person life insurance on, any of our key personnel.

      We believe our future success will also depend in large part upon our ability to attract and retain highly skilled managerial, engineering, sales and marketing, finance and manufacturing personnel. The competition for these employees is intense and we cannot assure you that we will be successful in attracting and retaining new personnel. The loss of the services of any of our key personnel, the inability to attract or retain qualified personnel in the future or delays in hiring required personnel, particularly engineers, could make it difficult for us to manage our business and meet key objectives, including the timely introduction of new products.

31


Table of Contents

 
      Changes in China’s political, social and economic environment may affect our financial performance.

      Our financial performance may be affected by changes in China’s political, social and economic environment. The role of the Chinese central and local governments in the Chinese economy is significant. Chinese policies toward economic liberalization, and laws and policies affecting technology companies, foreign investment, currency exchange rates and other matters could change, resulting in greater restrictions on our ability to do business and operate our manufacturing facilities in China. Any imposition of surcharges or any increase in Chinese tax rates could hurt our operating results. The Chinese government could revoke, terminate or suspend our license for national security and similar reasons without compensation to us. If the government of China were to take any of these actions, we would be prevented from conducting all or part of our business. Any failure on our part to comply with governmental regulations could result in the loss of our ability to manufacture our products in China.

      China has from time to time experienced instances of civil unrest and hostilities. Confrontations have occurred between the military and civilians. Events of this nature could influence the Chinese economy, result in nationalization of foreign-owned operations such as ours, and could negatively affect our ability to operate our facilities in China.

 
      The effect of terrorist threats and actions on the general economy could decrease our revenues.

      The United States continues to be on alert for terrorist activity. The potential near- and long-term impact terrorist activities may have in regards to our suppliers, customers and markets for our products and the U.S. economy are uncertain. There may be embargos of ports or products, or destruction of shipments or our facilities, or attacks that affect our personnel. There may be other potential adverse effects on our operating results due to a significant event that we cannot foresee.

 
      Our stock price has been and may continue to be volatile.

      Our stock price has fluctuated significantly since we began trading on the Nasdaq National Market. For the year ended December 31, 2003, the high and low closing sales prices of our common stock were $3.42 and $0.67, respectively. A number of factors could cause the price of our common stock to continue to fluctuate substantially, including:

  •  actual or anticipated fluctuations in our quarterly or annual operating results;
 
  •  changes in expectations about our future financial performance or changes in financial estimates of securities analysts;
 
  •  announcements of technological innovations by us or our competitors;
 
  •  new product introduction by us or our competitors;
 
  •  large customer orders or order cancellations; and
 
  •  the operating and stock price performance of comparable companies.

      In addition, the stock market in general has experienced extreme volatility that often has been unrelated to the operating performance of particular companies. These broad market and industry fluctuations may adversely affect the trading price of our common stock, regardless of our actual operating performance.

 
      We have adopted certain anti-takeover measures that may make it more difficult for a third party to acquire us.

      Our board of directors has the authority to issue up to 2,000,000 shares of preferred stock and to determine the price, rights, preferences and privileges of those shares without any further vote or action by the stockholders. The rights of the holders of common stock will be subject to, and may be adversely affected by, the rights of the holders of any preferred stock that may be issued in the future. The issuance of shares of preferred stock, while potentially providing desirable flexibility in connection with possible acquisitions and for

32


Table of Contents

other corporate purposes, could have the effect of making it more difficult for a third party to acquire a majority of our outstanding voting stock. We have no present intention to issue shares of preferred stock.

      Further, on April 24, 2001, our board of directors adopted a preferred stock purchase rights plan intended to guard against certain takeover tactics. The adoption of this plan was not in response to any proposal to acquire us, and the board is not aware of any such effort. The existence of this plan could also have the effect of making it more difficult for a third party to acquire a majority of our outstanding voting stock. In addition, certain provisions of our certificate of incorporation may have the effect of delaying or preventing a change of control, which could adversely affect the market price of our common stock.

      In addition, provisions in our amended and restated certificate of incorporation and bylaws may have the effect of delaying or preventing a merger, acquisition or change of control of us, or changes in our management, including:

  •  the division of our board of directors into three separate classes, each with three year terms;
 
  •  the right of our board to elect a director to fill a space created by a board vacancy or the expansion of the board;
 
  •  the ability of our board to alter our bylaws;
 
  •  the ability of our board to authorize the issuance of up to 2,000,000 shares of blank check preferred stock; and
 
  •  the requirement that only our board or the holders of at least 10% of our outstanding shares may call a special meeting of our stockholders.

      Furthermore, because we are incorporated in Delaware, we are subject to the provisions of Section 203 of the Delaware General Corporation Law. These provisions prohibit large stockholders, in particular those owning 15% or more of the outstanding voting stock, from consummating a merger or combination with a corporation unless:

  •  66 2/3% of the shares of voting stock not owned by these large stockholders approve the merger or combination, or
 
  •  the board of directors approves the merger or combination or the transaction which resulted in the large stockholder owning 15% or more of our outstanding voting stock.
 
      Legislative actions, higher insurance costs and potential new accounting pronouncements are likely to cause our general and administrative expenses to increase and impact our future financial position and results of operations.

      In order to comply with the newly adopted Sarbanes-Oxley Act of 2002, as well as proposed changes to listing standards by Nasdaq, and proposed accounting changes by the Securities and Exchange Commission, we may be required to increase our internal controls, hire additional personnel and additional outside legal, accounting and advisory services, all of which will cause our general and administrative costs to increase. Insurers may increase premiums as a result of the high claims rates they incurred over the past year, and our premiums for our various insurance policies, including our directors’ and officers’ insurance policies, increased during 2003. Proposed changes in the accounting rules, including legislative and other proposals to account for employee stock options as a compensation expense among others, could materially increase the expense that we report under generally accepted accounting principles and adversely affect our operating results.

 
      We need to continue to improve or implement our systems, procedures and controls and may not receive favorable attestation of our internal control systems by our independent auditors.

      The new requirements adopted by the Securities and Exchange Commission in response to the passage of the Sarbanes-Oxley Act of 2002 will require annual review and evaluation of our internal control systems, and attestation of these systems by our independent accountants. We are currently reviewing our internal control procedures and considering further documentation of such procedures that may be necessary. However, the

33


Table of Contents

guidelines for the evaluation and attestation of internal control systems have not yet been finalized. Furthermore, once the guidelines are finalized, the evaluation and attestation processes will be new and untested. Therefore, we can give no assurances that our systems will satisfy the new requirements of the Securities and Exchange Commission or that we will receive a favorable review and attestation by our independent auditors.
 
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
 
Foreign Currency Risk

      We use short-term forward exchange contracts for hedging purposes to reduce the effects of adverse foreign exchange rate movements. We have purchased foreign exchange contracts to hedge against certain trade accounts receivable denominated in Japanese yen. The change in the fair value of the forward contracts is recognized as part of the related foreign currency transactions as they occur. As of December 31, 2003, we had no outstanding commitments with respect to foreign exchange contracts.

 
Interest Rate Risk

      Cash and cash equivalents earning interest and certain variable rate debt instruments are subject to interest rate fluctuations. The following table sets forth the probable impact of a 10% change in interest rates (in thousands):

                                         
Current Proforma 10% Proforma 10%
Balance Current Interest Interest Rate Interest Rate
December 31, Interest Income/ Decline Increase
Instrument 2003 Rate (Expense) Income/(Expense) Income/(Expense)






Cash and cash equivalents
  $ 24,339       1.80 %   $ 438     $ 394     $ 482  
Bonds (see Note 5)
    8,450       1.35 %     (114 )     (103 )     (125 )
                     
     
     
 
                    $ 324     $ 291     $ 357  
                     
     
     
 
 
Equity Risk

      We also maintain minority investments in private and publicly traded companies. These investments are reviewed for other than temporary declines in value on a quarterly basis. Reasons for other than temporary declines in value include whether the related company would have insufficient cash flow to operate for the next twelve months, significant changes in the operating performance and changes in market conditions. In 2003, we recorded $2.0 million in charges to other expense to write down our investment in two private US companies. As of December 31, 2003, the minority investments we continue to hold totaled $4.3 million.

 
Item 8. Consolidated Financial Statements and Supplementary Data
 
Selected Quarterly Results of Operations

      The following table sets forth unaudited quarterly results in dollars and percentages for the eight quarters ended December 31, 2003. We believe that all necessary adjustments, consisting only of normal recurring

34


Table of Contents

adjustments, have been included in the amounts stated below to present fairly such quarterly information. The operating results for any quarter are not necessarily indicative of results for any subsequent period.
                                                                     
Quarters ended

Dec. 31, Sept. 30, June 30, Mar. 31, Dec. 31, Sept. 30, June 30, Mar. 31,
2003 2003 2003 2003 2002 2002 2002 2002








Revenue
  $ 9,129     $ 8,529     $ 8,519     $ 8,536     $ 8,503     $ 11,726     $ 12,897     $ 11,739  
Cost of revenue
    8,342       8,029       7,844       8,263       18,253       12,885       11,087       11,533  
     
     
     
     
     
     
     
     
 
Gross profit (loss)
    787       500       675       273       (9,750 )     (1,159 )     1,810       206  
Operating expenses:
                                                               
 
Selling, general and administrative
    2,502       2,654       2,819       2,500       2,752       3,495       3,441       4,172  
 
Research and development
    289       301       368       379       597       486       513       743  
 
Restructuring costs
                                  542       14,090        
     
     
     
     
     
     
     
     
 
   
Total operating expenses
    2,791       2,955       3,187       2,879       3,349       4,523       18,044       4,915  
     
     
     
     
     
     
     
     
 
Loss from operations
    (2,004 )     (2,455 )     (2,512 )     (2,606 )     (13,099 )     (5,682 )     (16,234 )     (4,709 )
Interest expense
    96       145       108       117       75       105       122       135  
Other (income) and expense, net
    15       (3 )     1,269       (231 )     4,520       (308 )     9,208       (717 )
     
     
     
     
     
     
     
     
 
Loss from continuing operations before provision for income taxes
    (2,115 )     (2,597 )     (3,889 )     (2,492 )     (17,694 )     (5,479 )     (25,564 )     (4,127 )
Provision (benefit) for income taxes
                            (2,314 )     10,673       (4,590 )     (1,650 )
     
     
     
     
     
     
     
     
 
Loss from continuing operations
    (2,115 )     (2,597 )     (3,889 )     (2,492 )     (15,380 )     (16,152 )     (20,974 )     (2,477 )
Discontinued operations:
                                                               
 
Loss from discontinued operations
          (1,591 )     (2,747 )     (1,825 )     (2,476 )     (19,533 )     (10,813 )     (1,803 )
 
Loss on disposal
          1,625       (11,100 )                              
 
Benefit for income taxes
                            (324 )     (7,012 )     (369 )     (722 )
     
     
     
     
     
     
     
     
 
Loss from discontinued operations
          34       (13,847 )     (1,825 )     (2,152 )     (12,521 )     (10,444 )     (1,081 )
     
     
     
     
     
     
     
     
 
Net loss
    (2,115 )     (2,563 )     (17,736 )     (4,317 )     (17,532 )     (28,673 )     (31,418 )     (3,558 )
     
     
     
     
     
     
     
     
 

35


Table of Contents

                                                                     
Quarters ended

Dec. 31, Sept. 30, June 30, Mar. 31, Dec. 31, Sept. 30, June 30, Mar. 31,
2003 2003 2003 2003 2002 2002 2002 2002








Revenue
    100.0 %     100.0 %     100.0 %     100.0 %     100.0 %     100.0 %     100.0 %     100.0 %
Cost of revenue
    91.4 %     94.1 %     92.1 %     96.8 %     214.7 %     109.9 %     86.0 %     98.2 %
     
     
     
     
     
     
     
     
 
Gross profit (loss)
    8.6 %     5.9 %     7.9 %     3.2 %     (114.7 )%     (9.9 )%     14.0 %     1.8 %
Operating expenses:
                                                               
 
Selling, general and administrative
    27.4 %     31.1 %     33.1 %     29.3 %     32.4 %     29.8 %     26.7 %     35.5 %
 
Research and development
    3.2 %     3.5 %     4.3 %     4.4 %     7.0 %     4.1 %     4.0 %     6.3 %
 
Restructuring costs
    0.0 %     0.0 %     0.0 %     0.0 %     0.0 %     4.6 %     109.3 %     0.0 %
     
     
     
     
     
     
     
     
 
   
Total operating expenses
    30.6 %     34.6 %     37.4 %     33.7 %     39.4 %     38.6 %     139.9 %     41.9 %
     
     
     
     
     
     
     
     
 
Loss from operations
    (22.0 )%     (28.7 )%     (29.5 )%     (30.5 )%     (154.1 )%     (48.5 )%     (125.9 )%     (40.1 )%
Interest expense
    1.1 %     1.7 %     1.3 %     1.4 %     0.9 %     0.9 %     0.9 %     1.2 %
Other (income) and expense, net
    0.2 %     0.0 %     14.9 %     (2.7 )%     53.2 %     (2.6 )%     71.4 %     (6.1 )%
     
     
     
     
     
     
     
     
 
Loss from continuing operations before provision for income taxes
    (23.3 )%     (30.4 )%     (45.7 )%     (29.2 )%     (208.1 )%     (46.7 )%     (198.2 )%     (35.2 )%
Provision (benefit) for income taxes
    0.0 %     0.0 %     0.0 %     0.0 %     (27.2 )%     91.0 %     (35.6 )%     (14.1 )%
     
     
     
     
     
     
     
     
 
Loss from continuing operations
    (23.3 )%     (30.4 )%     (45.7 )%     (29.2 )%     (180.9 )%     (137.7 )%     (162.6 )%     (21.1 )%
Discontinued operations:
                                                               
 
Loss from discontinued operations
    0.0 %     (18.7 )%     (32.2 )%     (21.4 )%     (29.1 )%     (166.6 )%     (83.8 )%     (15.4 )%
 
Loss on disposal
    0.0 %     19.1 %     (130.3 )%     0.0 %     0.0 %     0.0 %     0.0 %     0.0 %
 
Benefit for income taxes
    0.0 %     0.0 %     0.0 %     0.0 %     (3.8 )%     (59.8 )%     (2.9 )%     (6.2 )%
     
     
     
     
     
     
     
     
 
Loss from discontinued operations
    0.0 %     0.4 %     (162.5 )%     (21.4 )%     (25.3 )%     (106.8 )%     (81.0 )%     (9.2 )%
     
     
     
     
     
     
     
     
 
Net loss
    (23.3 )%     (30.0 )%     (208.2 )%     (50.6 )%     (206.2 )%     (244.5 )%     (243.6 )%     (30.3 )%
     
     
     
     
     
     
     
     
 

      Other Consolidated Financial Statements and Supplementary Data required by this item are set forth at the pages indicated at Item 14(a).

 
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures

      None.

Item 9A. Controls and Procedures

      (a) Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-14(c) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this report. Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

      (b) As required by Rule 13a-15(d), our management, including our principal executive officer and principal finance officer, also conducted an evaluation of our internal control over financial reporting to determine whether any changes occurred during the quarter covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Based on that evaluation, there has been no such change during the quarter covered by this report. It should be noted that any system of controls, however well designed and operated, can provide only reasonable and not absolute assurance that the objectives of the system will be met.

36


Table of Contents

PART III

      The SEC allows us to include information required in this report by referring to other documents or reports we have already or will soon be filing. This is called “Incorporation by Reference.” We intend to file our definitive proxy statement pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this report, and certain information therein is incorporated in this report by reference.

 
Item 10. Directors and Executive Officers of the Registrant.

      The information required by this Item is incorporated herein by reference to information set forth in our definitive proxy statement to be filed in connection with our annual meeting of stockholders to be held on May 18, 2004, under the section entitled “Proposal No. 1-Election of Directors.”

      Information concerning our executive officers is incorporated herein by reference to information set forth in our definitive proxy statement to be filed in connection with our annual meeting of stockholders to be held on May 18, 2004, under the section entitled “Executive Compensation and Other Matters.”

      The information required by this Item with respect to compliance with Section 16(a) of the Securities Exchange Act of 1934 is incorporated herein by reference to information set forth in the definitive Proxy statement to be filed in connection with our annual meeting of stockholders to be held on May 18, 2004, under the heading “Section 16(a) Beneficial Ownership Reporting Compliance.”

      We have revised our Insider Trading Policy to allow our directors, officers and other employees covered under the policy to establish, under limited circumstances contemplated by Rule 10b5-1 under the Securities Exchange Act of 1934, written programs that permit automatic trading of our stock or trading of our stock by an independent person (such as an investment bank) who is not aware of material inside information at the time of the trade. On February 28, 2003 Morris S. Young, our Chief Executive Officer, activated a trading plan under Rule 10b5-1. Some other of our directors or officers may establish such programs in future periods.

      We adopted a code of Business Conduct and Ethics that applies to our principal executive officer, principal financial officer, and other employees. A copy of this Code of Business Conduct and Ethics is filed as an exhibit to this Form 10-K.

 
Item 11. Executive Compensation.

      The information required by this Item is incorporated herein by reference to information set forth in our definitive Proxy statement to be filed in connection with our annual meeting of stockholders to be held on May 18, 2004, under the section entitled “Executive Compensation and Other Matters.”

 
Item 12. Security Ownership of Certain Beneficial Owners and Management, and Equity Compensation Plan Information.

      The information required by this Item is incorporated herein by reference to information set forth in our definitive Proxy statement to be filed in connection with our annual meeting of stockholders to be held on May 18, 2004, under the section entitled “Security Ownership of Certain Beneficial Owners and Management” and “Equity Compensation Plan Information.”

 
Item 13. Certain Relationships and Related Transactions

      Since January 2002, there has not been, nor is there currently proposed, any transaction or series of similar transactions to which we were or are to be a party in which the amount involved exceeds $60,000, and in which any director, executive officer or holder of more than 5% of any class of our voting securities or members of that person’s immediate family had or will have a direct or indirect material interest other than the transactions described below.

      We entered into an operating lease in July 2001 for warehouse space in Fremont, CA with 4160 Business Center, LLC, a real estate holding company, in which Davis Zhang, the president of our substrate division, is the sole shareholder. Lease payments to 4160 Business Center, LLC were approximately $121,000 for the

37


Table of Contents

three months ended March 31, 2003. In April of 2003, Mr. Zhang sold this warehouse to a party unrelated to the Company. We began leasing this warehouse from the new owner on the date of sale. Mr. Zhang will continue to hold a $3.7 million note on the property through April 2005.
 
Item 14. Principal Accountant Fees and Services

      The information required by this Item is incorporated herein by reference to information set forth in our definitive Proxy statement to be filed in connection with our annual meeting of stockholders to be held on May 18, 2004, under the section entitled “Principal Accountant Fees and Services.”

38


Table of Contents

PART IV

 
Item 15. Exhibits, Financial Statement Schedules, and Reports on Form 8-K

  (a)  The following documents are filed as part of this report:

  (1)  Financial Statements:

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

         
Report of Independent Auditors
    40  
Consolidated Balance Sheets
    41  
Consolidated Statements of Operations
    42  
Consolidated Statements of Stockholders’ Equity
    43  
Consolidated Statements of Cash Flows
    44  
Notes to Consolidated Financial Statements
    45-63  

  (2)  Financial Statement Schedules

      All schedules have been omitted because the required information is not present or not present in amounts sufficient to require submission of the schedules or because the information required is included in the Consolidated Financial Statements or Notes thereto.

        (3) Exhibits

      See Index to Exhibits on page 65 hereof. The exhibits listed in the accompanying Index to Exhibits are filed as part of, or incorporated by reference into, this report on Form 10-K.

      (b) Reports on Form 8-K

      We filed or furnished the following quarterly reports on Form 8-K during the quarter ended December 31, 2003:

        (1) We furnished the report on Form 8-K on October 22, 2003 reporting our financial results for the quarter ended September 30, 2003.

39


Table of Contents

REPORT OF INDEPENDENT AUDITORS

To the Board of Directors and Stockholders of AXT, Inc.:

      In our opinion, the accompanying consolidated balance sheets and the related consolidated statements of operations, of stockholders equity and cash flows present fairly, in all material respects, the financial position of AXT, Inc. and its subsidiaries at December 31, 2003 and 2002, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2003 in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of the Company’s management; our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with auditing standards generally accepted in the United States of America, which require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

/S/ PRICEWATERHOUSECOOPERS LLP

San Jose, California

March 5, 2004

40


Table of Contents

AXT, INC.

CONSOLIDATED BALANCE SHEETS

                     
December 31,

2003 2002


(In thousands, except
per share data)
ASSETS
Current assets
               
 
Cash and cash equivalents
  $ 24,339     $ 13,797  
 
Short-term investments
    14,669       8,205  
 
Accounts receivable, net
    6,297       7,195  
 
Inventories
    24,083       37,598  
 
Prepaid expenses and other current assets
    1,575       4,002  
 
Income tax receivable
          8,783  
 
Assets held for sale
    1,000       5,957  
     
     
 
   
Total current assets
    71,963       85,537  
Property, plant and equipment
    21,795       39,982  
Restricted deposits
    9,302       11,150  
Long-term investments
          3,657  
Other assets
    3,963       5,341  
     
     
 
   
Total assets
  $ 107,023     $ 145,667  
     
     
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
               
 
Accounts payable
  $ 2,638     $ 4,228  
 
Accrued liabilities
    8,296       11,407  
 
Current portion of long-term debt
    3,694       965  
 
Current portion of capital lease obligation
          3,562  
     
     
 
   
Total current liabilities
    14,628       20,162  
Long-term debt, net of current portion
    8,842       13,289  
Long-term capital lease, net of current portion
          4,847  
Other long-term liabilities
    1,255       1,712  
     
     
 
   
Total liabilities
    24,725       40,010  
     
     
 
Commitments and Contingencies (Note 14) 
               
Stockholders’ equity:
               
 
Preferred stock, $.001 par value; 2,000 shares authorized;
883 shares issued and outstanding
    3,532       3,532  
 
Common stock, $.001 par value; 70,000 shares authorized;
22,957 and 22,495 shares issued and outstanding
    155,178       154,485  
 
Accumulated deficit
    (78,928 )     (52,197 )
 
Other comprehensive income (loss)
    2,516       (163 )
     
     
 
   
Total stockholders’ equity
    82,298       105,657  
     
     
 
   
Total liabilities and stockholders’ equity
  $ 107,023     $ 145,667  
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

41


Table of Contents

AXT, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

                             
Years Ended December 31,

2003 2002 2001



(In thousands, except per share data)
Revenue
  $ 34,713     $ 44,865     $ 108,800  
Cost of revenue
    32,478       53,758       67,494  
     
     
     
 
Gross profit (loss)
    2,235       (8,893 )     41,306  
Operating expenses:
                       
 
Selling, general and administrative
    10,475       13,860       17,208  
 
Research and development
    1,337       2,339       3,876  
 
Restructuring costs
          14,632        
     
     
     
 
   
Total operating expenses
    11,812       30,831       21,084  
     
     
     
 
Income (loss) from operations
    (9,577 )     (39,724 )     20,222  
Interest expense
    466       437       831  
Other (income) and expense, net
    1,050       12,703       13,379  
     
     
     
 
Income (loss) from continuing operations before benefit for income taxes
    (11,093 )     (52,864 )     6,012  
Provision for income taxes
          2,119       2,164  
     
     
     
 
Income (loss) from continuing operations
    (11,093 )     (54,983 )     3,848  
Discontinued operations:
                       
 
Loss from discontinued operations
    (6,163 )     (34,625 )     (13,818 )
 
Loss on disposal
    (9,475 )            
 
Benefit for income taxes
          (8,427 )     (4,974 )
     
     
     
 
Loss from discontinued operations
    (15,638 )     (26,198 )     (8,844 )
     
     
     
 
Net loss
  $ (26,731 )   $ (81,181 )   $ (4,996 )
     
     
     
 
Basic income (loss) per share:
                       
 
Income (loss) from continuing operations
  $ (0.49 )   $ (2.46 )   $ 0.17  
 
Loss from discontinued operations
    (0.69 )     (1.17 )     (0.40 )
 
Net loss
    (1.18 )     (3.63 )     (0.23 )
Diluted income (loss) per share:
                       
 
Income (loss) from continuing operations
  $ (0.49 )   $ (2.46 )   $ 0.17  
 
Loss from discontinued operations
    (0.69 )     (1.17 )     (0.39 )
 
Net loss
    (1.18 )     (3.63 )     (0.23 )
Shares used in per share calculations:
                       
 
Basic
    22,781       22,433       22,278  
 
Diluted
    22,781       22,433       22,879  

The accompanying notes are an integral part of these consolidated financial statements.

42


Table of Contents

AXT, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

                                                                           
Preferred Stock Common Stock Other


Deferred Retained Comprehensive Comprehensive
Shares Amount Shares Amount Compensation Earnings Income/(loss) Total Income/(loss)









(In thousands)
Balance at December 31, 2000
    883     $ 3,532       21,952     $ 145,748     $ (107 )   $ 33,980     $ 2,194     $ 185,347     $ 23,828  
                                                                     
 
Common stock options exercised
                    388       3,862                               3,862          
Issuance of Employee Stock Purchase Plan stock
                    43       900                               900          
Income tax benefit from stock option exercises
                            3,125                               3,125          
Amortization of deferred compensation
                                    107                       107          
Comprehensive loss
                                                                       
 
Net loss
                                            (4,996 )             (4,996 )     (4,996 )
 
Unrealized gain (loss) on marketable securities
                                                    (2,052 )     (2,052 )     (2,052 )
 
Currency translation adjustment
                                                    29       29       29  
     
     
     
     
     
     
     
     
     
 
Balance at December 31, 2001
    883     $ 3,532       22,383     $ 153,635     $     $ 28,984     $ 171     $ 186,322     $ (7,019 )
                                                                     
 
Common stock options exercised
                    88       684                               684          
Issuance of Employee Stock Purchase Plan stock
                    24       166                               166          
Comprehensive loss
                                                                       
 
Net loss
                                            (81,181 )             (81,181 )     (81,181 )
 
Unrealized gain (loss) on marketable securities
                                                    (21 )     (21 )     (21 )
 
Currency translation adjustment
                                                    (313 )     (313 )     (313 )
     
     
     
     
     
     
     
     
     
 
Balance at December 31, 2002
    883     $ 3,532       22,495     $ 154,485     $     $ (52,197 )   $ (163 )   $ 105,657     $ (81,515 )
     
     
     
     
     
     
     
     
     
 
Common stock options exercised
                    33       73                               73          
Issuance of Employee Stock Purchase Plan stock
                    404       592                               592          
Issuance of common stock to board members
                    25       28                               28          
Comprehensive loss
                                                                     
 
Net loss
                                            (26,731 )             (26,731 )     (26,731 )
 
Unrealized gain (loss) on marketable securities
                                                    2,482       2,482       2,482  
 
Currency translation adjustment
                                                    197       197       197  
     
     
     
     
     
     
     
     
     
 
Balance at December 31, 2003
    883     $ 3,532       22,957     $ 155,178     $     $ (78,928 )   $ 2,516     $ 82,298     $ (24,052 )
     
     
     
     
     
     
     
     
     
 

The accompanying notes are an integral part of these consolidated financial statements.

43


Table of Contents

AXT, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

                                 
Years Ended December 31,

2003 2002 2001



(In thousands)
Cash flows from operating activities:
                       
 
Net loss
  $ (26,731 )   $ (81,181 )   $ (4,996 )
   
Adjustments to reconcile net loss to cash provided by operations:
                       
     
Depreciation
    5,782       9,493       8,538  
     
Deferred income taxes
          2,533       (5,041 )
     
Amortization
    502       403       554  
     
Stock compensation
    28             107  
     
Stock option tax benefits
                3,125  
     
Impairment of PP&E
          39,086        
     
Impairment of investments
    2,128       10,577       15,636  
     
Loss (gain) on disposal of property, plant and equipment
    (11 )     3,404       229  
     
Loss on disposal of a discontinued business
    9,475              
     
Changes in assets and liabilities:
                       
       
Accounts receivable, net
    232       8,489       11,939  
       
Inventories
    11,541       17,989       (3,741 )
       
Prepaid expenses
    2,217       (320 )     1,240  
       
Other assets
    (137 )     (362 )     (454 )
       
Accounts payable
    (1,590 )     1,285       (7,013 )
       
Accrued liabilities
    (5,493 )     (5,019 )     (2,967 )
       
Income tax receivable
    8,783       (6,091 )      
       
Other long-term liabilities
    (457 )     439       (12 )
     
     
     
 
       
Net cash provided by operating activities
    6,269       725       17,144  
     
     
     
 
Cash flows from investing activities:
                       
 
Purchases of property, plant and equipment
    (2,175 )     (14,238 )     (25,834 )
 
Investment in marketable securities
    (5,941 )     (17,869 )     (21,591 )
 
Investment in other assets
                (1,307 )
 
Proceeds from sale of marketable securities
    13,885       17,070       1,034  
 
Proceeds from sale of property and equipment from discontinued opto-electronics business (Note 2)
    8,600                  
 
Proceeds from sale of property located in Fremont, California (Note 3)
    5,172              
 
Increase in restricted cash
    (5,818 )     (1,000 )      
     
     
     
 
       
Net cash provided by (used in) investing activities
    13,723       (16,037 )     (47,698 )
     
     
     
 
Cash flows from financing activities:
                       
 
Proceeds from (payments of):
                       
   
Issuance of common stock
    480       850       4,762  
   
Capital lease payments
    (8,409 )     (5,965 )     (4,274 )
   
Capital lease borrowings
                3,143  
   
Short-term bank borrowings
                (1,353 )
   
Long-term debt borrowings
          3,935        
   
Long-term debt payments
    (1,718 )     (6,936 )     (2,800 )
     
     
     
 
       
Net cash used in financing activities
    (9,647 )     (8,116 )     (522 )
     
     
     
 
Effect of exchange rate changes
    197       (313 )     29  
     
     
     
 
Net increase (decrease) in cash and cash equivalents
    10,542       (23,741 )     (31,047 )
Cash and cash equivalents at the beginning of the period
    13,797       37,538       68,585  
     
     
     
 
Cash and cash equivalents at the end of the period
  $ 24,339     $ 13,797     $ 37,538  
     
     
     
 
Non cash activity:
                       
 
Purchases of property, plant and equipment through financing
  $     $ 577     $ 2,170  
Supplemental Disclosures:
                       
 
Interest paid
  $ 790     $ 1,326     $ 2,081  

The accompanying notes are an integral part of these consolidated financial statements.

44


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 
Note 1. The Company and Summary of Accounting Policies
 
The Company

      AXT designs, develops, manufactures and distributes high-performance compound semiconductor substrates. AXT’s substrate products are used primarily in wireless communications, lighting display applications, and fiber optic communications.

      On June 24, 2003, the Company’s Board of Directors approved management’s plan to exit the Company’s unprofitable Opto-electronics business. Substantially all of the assets of this division were sold in September 2003. The decision to dispose of the business was due to continuing operating losses and negative cash flows from the division and significant uncertainty regarding future profitability.

      The Company officially changed its name from American Xtal Technology, Inc. to AXT, Inc. on July 7, 2000.

 
Use of Estimates

      The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from these estimates.

 
Principles of Consolidation

      The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated. Investments in business entities in which AXT does not have control, but has the ability to exercise significant influence over operating and financial policies (generally 20-50% ownership), are accounted for by the equity method.

 
Foreign Currency Translation

      The functional currencies of the Company’s Japanese and Chinese subsidiaries are the local currencies. Transaction gains and losses resulting from transactions denominated in currencies other than the U.S. dollar for the Company or in the functional currencies for the subsidiaries are included in other (income) expense for the periods presented.

      The assets and liabilities of the subsidiaries are translated at the rates of exchange on the balance sheet date. Revenue and expense items are translated at the average rate of exchange for the period. Gains and losses from foreign currency translation are included in other comprehensive income in stockholders’ equity.

 
Revenue Recognition

      The Company recognizes revenue upon the shipment of its products to the customer provided that the Company has received a signed purchase order, the price is fixed or determinable, title has transferred, collection of resulting receivables is probable, product returns are reasonably estimable, there are no customer acceptance requirements and there are no remaining significant obligations. The Company provides for future returns based on historical experience at the time revenue is recognized. The Company does not provide for warranty related exposure as such exposure has historically been immaterial.

45


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
Fair Value of Financial Instruments

      The reported amounts of certain of the Company’s financial instruments including cash and cash equivalents, accounts receivable, short-term investments, accounts payable and accrued liabilities approximate fair value due to their short maturities. The reported amounts of short-term and long-term debt approximate fair value due to the market interest rates that these debts bear, and interest rates currently available to the Company.

 
Concentration of Credit Risk

      Financial instruments, which potentially subject the Company to concentration of credit risk, consist primarily of cash and cash equivalents and trade accounts receivable. The Company performs ongoing credit evaluations of its customers’ financial condition, and limits the amount of credit extended when deemed necessary, but generally does not require collateral. The Company invests primarily in money market accounts and commercial paper instruments. Cash equivalents are maintained with high quality institutions and their composition and maturities are regularly monitored by management.

      No customer represented greater than 10% of product revenues for the years ended December 31, 2003, 2002 and 2001. The company’s top five customers represented 28.9% of product revenue for the year ended December 31, 2003, 31.4% of product revenue for the year ended December 31, 2002, and 31.1% of product revenue for the year ended December 31, 2001. We expect that sales to certain customers will continue to comprise a significant portion of our revenue in the future.

      No customer accounted for 10% or more of the trade accounts receivable balance as of December 31, 2003 and 2002.

 
Cash Equivalents

      The Company considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.

 
Investments

      Management determines the appropriate classification of investments at the time of purchase. Available-for-sale investments are carried at their fair value based on quoted market prices as of the balance sheet date. The amortized cost of securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is included in “other (income) and expense, net.” Realized gains or losses are determined on the specific identification method and are reflected in “other (income) and expense, net.” Net unrealized gains or losses are recorded directly in stockholders’ equity. Those unrealized losses that are deemed to be other than temporary are reflected in “interest and other income, net.” The Company also maintains minority investments in private companies which are accounted for under the costs basis. These investments are reviewed for other than temporary declines in value on a quarterly basis. Reasons for other than temporary declines in value include whether the related company would have insufficient cash flow to operate for the next twelve months, significant changes in the operating performance and changes in market conditions.

 
Inventories

      Inventories are stated at the lower of cost (approximated by standard cost) or market. Cost is determined using the weighted average cost method. Finished goods and work-in-process inventories include material, labor and manufacturing overhead costs.

46


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
Property, Plant and Equipment

      Property, plant and equipment are stated at cost less accumulated depreciation computed using the straight-line method over the estimated economic lives of the assets, which vary from 3 to 27.5 years. Leasehold improvements are amortized over the shorter of the estimated useful life or the term of the lease. We generally depreciate computers and software over 3 years, automobiles over 5 years, office equipment, furniture and fixtures over 3 years, leasehold improvements over 10 years, and buildings over 27.5 years. Depreciation expense was $5.8 million, $9.5 million, and $8.5 million for the years ended 2003, 2002, and 2001 respectively.

 
Impairment of Long-Lived Assets

      Management evaluates the recoverability of property, equipment, and intangible assets in accordance with Statement of Financial Accounting Standards No. 144, or SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets.” When events and circumstance indicate that long-lived assets may be impaired, management compares the carrying value of the long-lived assets to the projection of future undiscounted cash flows attributable to such assets and in the event that the carrying value exceeds the future undiscounted cash flows, management records an impairment charge against income equal to the excess of the carrying value over the asset’s fair value.

 
Stock-Based Compensation

      The Company accounts for stock-based employee compensation arrangements using the intrinsic value method as prescribed in Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” and related interpretations thereof. Accordingly, compensation cost for stock options is measured as the excess, if any, of the market price of the Company’s stock at the date of grant over the stock option exercise price. In addition, the Company provides additional disclosure provisions as required under Statement of Financial Accounting Standard No. 123, “Accounting for Stock-Based Compensation” and SFAS 148, “Accounting for Stock- Based Compensation — Transition and Disclosure” in Note 13.

 
Research and Development

      Research and development costs are expensed as incurred.

 
Income Taxes

      The Company accounts for deferred income taxes using the liability method, under which the expected future tax consequences of timing differences between the book and tax basis of assets and liabilities are recognized as deferred tax assets and liabilities. Valuation allowances are established when necessary to reduce net deferred tax assets when management estimates, based on available objective evidence, that it is more likely than not that the future income tax benefit represented by the net deferred tax asset will not be realized.

 
Comprehensive Income

      Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances, excluding transactions resulting from investment by owners and distribution to owners. The difference between net income and comprehensive income for the Company relates to foreign currency translation adjustments and unrealized gains and losses on investment securities. Comprehensive income for the years ended December 31, 2003, 2002 and 2001 is disclosed in the “Consolidated Statements of Stockholders’ Equity.”

47


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
Basic and Diluted Net Income (Loss) Per Share

      Basic income (loss) per share is computed by dividing the income (loss) available to holders of common stock for the period by the weighted average number of shares of common stock outstanding during the period. The calculation of diluted income (loss) per share excludes potential common stock if the effect of such stock is antidilutive. Potential common stock consists of common shares issuable upon the exercise of stock options.

 
Reclassifications

      Certain reclassifications have been made to the prior years’ consolidated financial statements to conform to current period presentation.

 
Recent Accounting Pronouncements

      In November 2002, the FASB issued FASB Interpretation No. 45 ( FIN 45 ), “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others.” FIN No. 45 requires that a liability be recorded in the guarantor’s balance sheet upon issuance of a guarantee. In addition, FIN No. 45 requires disclosures about the guarantees that an entity has issued, including a reconciliation of changes in the entity’s product warranty liabilities. The initial recognition and initial measurement provisions of FIN No. 45 are applicable on a prospective basis to guarantees issued or modified after December 31, 2002, irrespective of the guarantor’s fiscal year-end. The disclosure requirements of FIN No. 45 are effective for financial statements of interim or annual periods ending after December 15, 2002. Our adoption of FIN No. 45 did not have a material effect on our consolidated financial statements.

      In January 2003, the FASB issued FASB Interpretation No. 46 ( FIN 46 ), “Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51.” FIN 46 requires certain variable interest entities to be consolidated by the primary beneficiary of the entity if the equity investors in the entity do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46 is effective immediately for all new variable interest entities created or acquired after January 31, 2003. For variable interest entities created or acquired prior to February 1, 2003, the provisions of FIN 46 must be applied for the first interim or annual period beginning after December 15, 2003. Our adoption of FIN No. 46 did not have a material effect on our consolidated financial statements.

      In March 2003, the Emerging Issues Task Force, or EITF, reached a consensus on EITF Issue No. 00-21, “Revenue Arrangements with Multiple Deliverables.” EITF Issue No. 00-21 requires revenue arrangements with multiple deliverables to be divided into separate units of accounting if the deliverables in the arrangement meet certain criteria. The arrangement’s consideration should be allocated among the separate units of accounting based on their relative fair values. Applicable revenue recognition criteria should be considered separately for each unit. The provisions of EITF Issue No. 00-21 are effective for revenue arrangements entered into in fiscal periods beginning after June 15, 2003. Our adoption of EITF Issue No. 00-21 did not have a material effect on our consolidated financial statements.

      In April 2003, the FASB issued SFAS No. 149, “Amendment of Statement 133 on Derivative Instruments and Hedging Activities.” This Statement amends and clarifies financial accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts (collectively referred to as derivatives), and for hedging activities under SFAS No. 133, “Accounting for Derivative Instruments and Hedging Activities.” This Statement is effective for contracts entered into or modified after June 30, 2003, and for hedging relationships designated after June 30, 2003. Our adoption of SFAS No. 149 did not have a material effect on our consolidated financial statements.

      In May 2003, the FASB issued SFAS No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity.” SFAS No. 150 establishes standards for an issuer to classify

48


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

and measure certain financial instruments with characteristics of both liabilities and equity. This Statement requires an issuer to classify a financial instrument that meets certain characteristics as a liability (or an asset in some circumstances). This Statement is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective at the beginning of the first interim period beginning after June 15, 2003. Our adoption of SFAS No. 150 did not have a material effect on our consolidated financial statements.

 
Note 2. Discontinued Operations

      On June 24, 2003, the Company announced the discontinuation of its opto-electronics division, which was established as part of the acquisition of Lyte Optronics, Inc. in May 1999. Accordingly, the results of operations of the opto-electronics division have been segregated from continuing operations and are reported separately as discontinued operations in the consolidated statements of operations. The discontinued opto-electronics division manufactured blue, cyan, and green high-brightness light emitting diodes (HBLEDs) for the illumination markets, including full-color displays, wireless handset backlighting and traffic signals, and also manufactured vertical cavity surface emitting lasers (VCSELs) and laser diodes for fiber optic communications and storage area networks.

      On September 27, 2003 the Company completed a sale of substantially all of the assets of its opto-electronics business to Lumei Optoelectronics, Corp. and Dalian Luming Science and Technology Group, Co., Ltd. for the Chinese Renminbi equivalent of $9.6 million. Proceeds of $1.0 million will be held in escrow for up to one year and will not be recorded until all claims, if any, are settled. If unclaimed, up to $250,000 of the sale proceeds will be held in escrow for a second year and will not be recorded until all claims, if any, are settled. The Company retains a building located in Monterey Park, CA, that it expects to sell in 2004. This asset is classified as Held for Sale on the consolidated balance sheet at December 31, 2003.

      The Company recorded a loss on disposal of $9.5 million to write-down the book value of assets sold to their estimated fair market value.

      The Company’s financial statements have been presented to reflect the opto-electronics business as a discontinued operation for all periods presented. Operating results of the discontinued operation are as follows:

                             
Years Ended December 31,

2003 2002 2001



Revenue
  $ 7,245     $ 18,310     $ 10,730  
Cost of revenue
    9,972       20,273       14,697  
     
     
     
 
Gross profit (loss)
    (2,727 )     (1,963 )     (3,967 )
Operating expenses:
                       
 
Selling, general and administrative
    2,297       4,788       4,279  
 
Research and development
    814       2,529       4,328  
 
Impairment costs
          24,454        
     
     
     
 
   
Total operating expenses
    3,111       31,771       8,607  
     
     
     
 
Loss from operations
    (5,838 )     (33,734 )     (12,574 )
Interest expense
    325       891       1,244  
     
     
     
 
Loss before benefit for income taxes and loss on disposal
    (6,163 )     (34,625 )     (13,818 )
Income tax (benefit)
          (8,427 )     (4,974 )
Loss on disposal
    (9,475 )            
     
     
     
 
Net loss
  $ (15,638 )   $ (26,198 )   $ (8,844 )
     
     
     
 

49


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      The carrying value of the assets and liabilities of the discontinued opto-electronics business included in the consolidated balance sheets are as follows:

                     
Years Ended
December 31,

2003 2002


Current assets:
               
 
Cash
  $ 539     $ 336  
 
Accounts receivable, net
    250       3,224  
 
Inventories
          3,439  
 
Assets held for sale
    1,000        
 
Other current assets
          2,482  
     
     
 
   
Total current assets
    1,789       9,481  
Propert, plant and equipment
          14,854  
Other assets
    200       200  
     
     
 
   
Total assets
  $ 1,989     $ 24,535  
     
     
 
Current liabilities:
               
 
Accounts payable
  $ 43     $ 1,975  
 
Accrued liabilites
    1,232       2,806  
     
     
 
   
Total liabilities
    1,275       4,781  
Net assets
    714       19,754  
     
     
 
Total liabilities and net assets
  $ 1,989     $ 24,535  
     
     
 

      Assets held for sale consist of a building and are carried at management’s estimated fair value less costs to sell, totaling $1.0 million at December 31, 2003.

 
Note 3. Assets Held for Sale

      Assets held for sale at December 31, 2003 consist of a property located in Monterey Park, California, which is part of the Company’s discontinued opto-electronics division (see Note 2). Assets held for sale at December 31, 2002 consist of a property located at 4281 Technology Drive, Fremont, California. In November of 2002, the Company entered into a contract to sell this property to a third party. On March 11, 2003, the Company completed the sale of its property located at 4281 Technology Drive, Fremont, California, for $6.3 million. Net cash proceeds from the sale were $5.2 million. The gain the Company incurred on this transaction was less than $15,000. Under the terms of the sale agreement, the Company has agreed to lease back the property for a ten-year period. Accordingly, on March 11, 2003, the Company signed an operating lease for this property through March 2013. Annual rent under this operating lease is approximately $600,000.

 
Note 4. Inventories

      Inventories are stated at the lower of cost or net realizable value. Cost is determined using the weighted average cost method. Finished goods and work-in-process inventories include material, labor and manufacturing overhead costs. The Company routinely evaluates the levels of its inventory in light of current market conditions in order to identify excess and obsolete inventory and provides a valuation allowance for certain inventories based upon the age and quality of the product.

50


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      The components of inventory are summarized below (in thousands):

                   
Years Ended
December 31,

2003 2002


Inventories:
               
 
Raw materials
  $ 7,086     $ 12,559  
 
Work in process
    16,027       22,950  
 
Finished goods
    970       2,089  
     
     
 
    $ 24,083     $ 37,598  
     
     
 
 
Note 5. Debt
 
Credit Facility

      At December 31, 2003 the credit facility maintained by the Company with a bank included a letter of credit supporting repayment of its industrial bonds with an outstanding amount of $8.5 million. The Company has pledged and placed cash and certain investment securities with the trust department of the bank as additional collateral for this facility. The Company has also pledged cash for a credit facility for workers compensation insurance. As a result, $9.3 million of cash and long-term investments are restricted.

51


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
Long-Term Debt

      The components of long-term debt are summarized below (in thousands):

                 
Year Ended
December 31,

2003 2002


Various notes payable to banks, secured by certain equipment, bearing interest at fixed rates between 4.55% and 4.72%
  $     $ 1,083  
Debenture loan to Bay Area Employment Development Company, guaranteed by the U.S. Small Business Administration, bearing interest at a fixed rate of 7.27%, maturing October 2016
    788       823  
Taxable revenue bonds, secured by a letter of credit from a bank, bearing interest at the H15 30 day bond yield for commercial paper which was 1.35% on December 31, 2003, maturing December 2023
    8,450       9,050  
Notes payable to a bank, secured by certain equipment in China, bearing interest at a fixed rate of 5.49%, maturing December 2004
    3,298       3,298  
     
     
 
      12,536       14,254  
Less current portion
    (3,694 )     (965 )
     
     
 
    $ 8,842     $ 13,289  
     
     
 
Maturities of long-term debt at December 31, 2003 were as follows:
               
2004
    3,694          
2005
    514          
2006
    459          
2007
    462          
2008
    466          
Thereafter
    6,941          
     
         
    $ 12,536          
     
         
 
Note 6. Investments in Marketable Securities

      The Company classifies its investment securities as available-for-sale securities as prescribed by Statement of Financial Accounting Standards No. 115 or SFAS 115, “Accounting for Certain Investments in Debt and Equity Securities.” All investments are carried at fair market value, which is determined based on

52


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

quoted market prices, with net unrealized gains and losses included in comprehensive income, net of tax. The components of investments at December 31, 2003 are summarized below (in thousands):

                         
Aggregate
Unrealized Fair
Available for Sale Cost Gain/(Loss) Value




Money market
  $ 17,495     $     $ 17,495  
Corporate bonds
    8,469       378       8,847  
Government agency bonds
    4,155       (344 )     3,811  
Corporate equity securities
    1,115       2,560       3,675  
     
     
     
 
    $ 31,234     $ 2,594     $ 33,828  
     
     
     
 
Recorded as:
                       
Cash equivalents
  $ 9,857                  
Short-term investments
    14,669                  
Restricted deposits
    9,302                  
     
                 
    $ 33,828                  
     
                 
 
Note 7. Corporate Affiliates

      The Company’s corporate affiliates are summarized below (in thousands):

                                 
Investment Balance
at December 31,

Accounting Ownership
Affiliate 2003 2002 Method Percentage





Xilingol Tongli Ge Co. Ltd.
  $ 822     $ 773       Equity       25 %
Emeishan Jia Mei High Pure Metals Co., Ltd.
    603       614       Equity       25 %
Beijing Ji Ya Semiconductor Material Co., Ltd.
    1,071       1,071       Consolidated       51 %
Nanjing Jin Mei Gallium Co., Ltd.
    616       616       Consolidated       88 %
Beijing BoYu Manufacturing Co., Ltd
    409       409       Consolidated       70 %

      The investment balances for those affiliates accounted for under the equity method are included within “Other assets” in the consolidated balance sheets.

      Undistributed retained earnings relating to the Company’s corporate affiliates, was $769,000 at December 31, 2003 and $861,000 at December 31, 2002. Net income/(loss) recorded from the Company’s corporate affiliates was ($92,000) for the year ended December 31, 2003, $131,000 for 2002, and $701,000 for 2001.

      The Company invested in these companies because each provides materials that are important to the Company’s substrate business, each can provide products at lower cost than other suppliers, and each has a market beyond that provided by the Company. At December 31, 2003, the Company had no obligations to make further investments in any of these companies, although it may choose to do so under certain conditions.

 
Note 8. Impairment of Investments

      The Company also maintains minority investments in private companies which are accounted for under the cost basis. These investments are reviewed for other than temporary declines in value on a quarterly basis. Reasons for other than temporary declines in value include whether the related company would have insufficient cash flow to operate for the next twelve months, significant changes in the operating performance and changes in market conditions. In 2003, the Company recorded $2.0 million in charges to other expense to

53


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

write down its investment in two private US companies. As of December 31, 2003, the minority investments the Company continues to hold totaled $602,000.

 
Note 9. Balance Sheet Detail

      The components of selected balance sheet accounts are summarized below (in thousands):

                 
Years Ended
December 31,

2003 2002


Accounts receivable:
               
Accounts receivable, gross
  $ 10,601     $ 13,871  
Allowance for doubtful accounts
    (4,304 )     (6,676 )
     
     
 
    $ 6,297     $ 7,195  
     
     
 
The reduction in allowance for doubtful accounts was due to the collection of previously written-down receivables.
Property, plant and equipment:
               
Land
  $ 1,120     $ 1,722  
Building
    17,180       15,849  
Machinery and equipment
    8,275       13,142  
Leasehold improvements
    443       2,600  
Construction in progress
    1,150       7,260  
     
     
 
      28,168       40,573  
Less: accumulated depreciation and amortization
    (6,373 )     (591 )
     
     
 
    $ 21,795     $ 39,982  
     
     
 
Accrued liabilities:
               
Accrued compensation
  $ 1,012     $ 1,304  
Customer deposits
    994       2,196  
Accrued restructuring costs
          1,254  
Income tax payable
    3,063       3,063  
Other
    3,227       3,590  
     
     
 
    $ 8,296     $ 11,407  
     
     
 

54


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
Note 10. Income Taxes

      The components of the benefit for income taxes for income (loss) are summarized below (in thousands):

                             
Years Ended December 31,

2003 2002 2001



Current:
                       
 
Federal
  $     $ (8,841 )   $ 1,917  
 
State
                 
 
Foreign
                314  
     
     
     
 
   
Total current
          (8,841 )     2,231  
     
     
     
 
Deferred:
                       
 
Federal
          1,301       (3,481 )
 
State
          1,232       (1,560 )
     
     
     
 
   
Total deferred
          2,533       (5,041 )
     
     
     
 
   
Total net benefit for income taxes
  $     $ (6,308 )   $ (2,810 )
     
     
     
 

      A reconciliation of the effective income tax rates and the U.S. statutory federal income tax rate is summarized below:

                         
Years Ended December 31,

2003 2002 2001



Statutory federal income tax rate
    (35.00 )%     (35.0 )%     (35.0 )%
State income taxes, net of federal tax benefits
    (1.71 )%     (2.7 )%     (5.0 )%
Foreign sales corporation benefit
    0.00 %     0.0 %     0.0 %
Unbenefited losses and credits
    35.83 %     29.9 %     0.0 %
Change in valuation allowance
    0.00 %     2.8 %     0.0 %
Other
    0.88 %     (2.2 )%     4.0 %
     
     
     
 
Effective tax rate
    0.00 %     (7.2 )%     (36.0 )%
     
     
     
 

55


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      Deferred tax assets and liabilities are summarized below (in thousands):

                   
Years Ended
December 31,

2003 2002


Deferred tax assets:
               
 
Accruals and reserves not yet deductible
  $ 7,624     $ 15,337  
 
Net operating loss
    28,170       8,923  
 
Depreciation
          5,519  
 
Credits
    4,212       3,477  
     
     
 
    $ 40,006     $ 33,256  
Deferred tax liabilities:
               
 
Unrealized appreciation on Finisar marketable securities
           
 
State taxes
    (526 )     (980 )
 
Gain on receipt of Finisar marketable securities
             
 
Unrepatriated Foreign Earnings
    (1,239 )     (1,085 )
 
Depreciation
    (3,634 )      
     
     
 
    $ (5,399 )   $ (2,065 )
     
     
 
 
Net deferred tax assets
  $ 34,607     $ 31,191  
 
Valuation allowance
    (34,607 )     (31,191 )
 
Net deferred tax assets
           
     
     
 

      At December 31, 2003, the Company had federal and state net operating loss carryforwards of approximately $75.9 million and $31.4 million, respectively, which will expire beginning in 2020 and 2005, respectively. In addition, the Company had federal tax credit carryforwards of approximately $1.6 million, which will expire beginning in 2019. The Company also has state tax credit carryforwards of approximately $2.7 million which will expire beginning 2007.

      The deferred tax assets valuation allowance at December 31, 2003 is attributed to U.S. federal, and state deferred tax assets, which result primarily from future deductible accruals, reserves, net operating loss carryforwards, and tax credit carryforwards. The Company believes that, based on a number of factors, the available objective evidence creates sufficient uncertainty regarding the realizability of the deferred tax assets such that a full valuation allowance has been recorded. These factors include the Company’s history of losses, and the lack of carryback capacity to realize deferred tax assets.

      In accordance with Section 382 of the Internal Revenue Code, the amounts of and benefits from net operating loss and tax credit carryforwards may be impaired or limited in certain circumstances. Events which cause limitations in the amount of net operating losses or credits that the Company may utilize in any one year include, but are not limited to, a cumulative ownership change of more than 50% as defined, over a three year period.

56


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
Note 11. Net loss per Share

      A reconciliation of the numerators and denominators of the basic and diluted net loss per share calculations is as follows (in thousands, except per share data):

                             
Years Ended December 31,

2003 2002 2001



Numerator:
                       
 
Income (loss) from continuing operations
  $ (11,093 )   $ (54,983 )   $ 3,848  
 
Loss from discontinued operations
    (15,638 )     (26,198 )     (8,844 )
 
Less: Preferred stock dividends
    (177 )     (177 )     (177 )
     
     
     
 
 
Net loss to common stockholders
  $ (26,908 )   $ (81,358 )   $ (5,173 )
     
     
     
 
Denominator:
                       
 
Denominator for basic net loss per share — weighted average common shares
    22,781       22,433       22,278  
 
Effect of dilutive securities:
                       
   
Common stock options
                601  
     
     
     
 
Denominator for dilutive net loss per share
    22,781       22,433       22,879  
     
     
     
 
Basic income (loss) per share:
                       
 
Income (loss) from continuing operations
  $ (0.49 )   $ (2.46 )   $ 0.17  
 
Loss from discontinued operations
    (0.69 )     (1.17 )     (0.40 )
 
Net loss to common stockholders
    (1.18 )     (3.63 )     (0.23 )
Diluted income (loss) per share:
                       
 
Income (loss) from continuing operations
  $ (0.49 )   $ (2.45 )   $ 0.17  
 
Loss from discontinued operations
    (0.69 )     (1.17 )     (0.39 )
 
Net loss to common stockholders
    (1.18 )     (3.63 )     (0.23 )
Options excluded from diluted net loss per share as the impact is antidilutive
    2,326       2,867       2,107  
     
     
     
 
 
Note 12. Stockholders’ Equity

      In May 1998, the Company completed its initial public offering, or IPO, and issued 2,875,000 shares of its common stock at $10.00 per share, including the shares from the exercise of the underwriters’ over-allotment option. The Company received cash of approximately $25.8 million net of underwriting discounts, commissions and IPO expenses. Upon the closing of the IPO, all outstanding shares of the Company’s then convertible preferred stock were automatically converted into shares of common stock.

      On May 28, 1999, the Company completed its acquisition of Lyte Optronics, Inc. Under the terms of the acquisition, the Company issued approximately 2,023,000 shares of common stock and 883,000 shares of non-voting and non-convertible preferred stock, in exchange for all of the issued and outstanding shares of the capital stock of Lyte. Dividends accrue on non-convertible preferred stock at the rate of $0.20 per annum per share and are payable when declared by the board of directors of the Company or in the case of a change in control. The preferred stock has a $4 per share liquidation preference over common stock.

      On July 25, 2000 the Company completed a private securities offering, raising approximately $8.5 million in exchange for 234,115 shares of common stock.

57


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      On September 19, 2000, the Company sold, pursuant to an underwritten public offering, 2,510,000 shares of its common stock at a price of $34.25 per share, including the shares from the exercise of the underwriters’ over-allotment option. The Company received cash of approximately $80.8 million net of underwriting discounts, commissions and expenses. Following the public offering, proceeds were used to repay its line of credit and for general corporate purposes.

 
Note 13. Employee Benefit Plans

     Stock Option Plans

      In March 1993, the Company’s board of directors approved the 1993 Stock Option Plan (“1993 Plan”), which provided for granting of incentive and non-qualified stock options to employees and directors of the Company. Under the 1993 Plan, 880,000 shares of common stock were reserved for issuance as of December 31, 1998. Options granted under the 1993 Plan were generally for periods not to exceed ten years and were granted at the fair market value of the stock at the date of grant as determined by the board of directors. Options granted under the 1993 Plan generally vested 25.0% upon grant and 25.0% each year thereafter, with full vesting occurring on the third anniversary of the grant date. This plan terminated on March 12, 2003.

      In July 1997, the Company’s board of directors approved the 1997 Stock Option Plan (“1997 Plan”), which provides for granting of incentive and non-qualified stock options to employees and directors of the Company. Under the 1997 Plan, 5,901,501 shares of common stock have been reserved for issuance as of December 31, 2003. Options granted under the 1997 Plan are generally for periods not to exceed ten years (five years if the option is granted to a 10.0% stockholder) and are granted at the fair market value of the stock at the date of grant as determined by the board of directors. Options granted under the 1997 Plan generally vest 25.0% at the end of one year and 2.1% each month thereafter, with full vesting after four years.

      The following summarizes the Company’s stock option activity under the 1993 Plan and the 1997 Plan, and related weighted average exercise price within each category for each of the years ended December 31, 2001, 2002, and 2003:

                                   
Available Number of Price per
For Grant Shares Price per Share Share




Balance at December 31, 2000
    2,936,898       2,495,229             $ 20.46  
 
Granted
    (1,693,070 )     1,693,070     $ 10.30 - 43.88       16.71  
 
Exercised
          (388,617 )     5.00 - 39.00       9.94  
 
Cancelled
    485,272       (485,272 )     5.00 - 44.25       22.14  
     
     
                 
Balance at December 31, 2001
    1,729,100       3,314,410             $ 19.63  
 
Granted
    (1,137,450 )     1,137,450     $ 1.92 - 15.90       3.06  
 
Exercised
          (23,791 )     5.00 - 9.125       6.94  
 
Cancelled
    863,204       (863,204 )     5.00 - 42.50       20.10  
     
     
                 
Balance at December 31, 2002
    1,454,854       3,564,865             $ 14.15  
 
Granted
    (1,116,964 )     1,116,964     $ 0.84 -  3.11       2.29  
 
Exercised
          (32,815 )     2.19 -  2.19       2.19  
 
Cancelled
    2,060,178       (2,060,178 )     1.38 - 43.88       15.64  
     
     
                 
Balance at December 31, 2003
    2,398,068       2,588,836             $ 10.79  
     
     
                 

58


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      Information about stock options outstanding at December 31, 2003 is summarized below:

                                 
Options Outstanding Options Exercisable


Weighted
Average Weighted
Remaining Average
Range of Number Contractual Number Exercise
Exercise Prices Outstanding Life Outstanding Price





$ 0.84 - 1.34
    8,500       9.12       677     $ 0.84  
  1.38 - 1.38
    462,900       9.55              
  1.40 - 2.10
    42,000       9.48       3,937       1.61  
  2.19 - 2.19
    646,330       8.89       177,043       2.19  
  2.74 - 3.01
    16,000       9.94              
  3.11 - 3.11
    522,754       10.00       289,064       3.11  
  5.00 - 12.12
    393,375       5.90       270,501       7.84  
 12.90 - 22.69
    274,310       7.00       160,643       17.06  
 24.00 - 39.80
    217,667       6.37       153,501       26.40  
$41.50 - 41.50
    5,000       6.43       4,167       41.50  
     
     
     
     
 
      2,588,836       8.38       1,059,533     $ 9.80  
     
     
     
     
 
 
      Stock-Based Compensation Under APB No. 25

      In connection with certain stock option grants the Company recorded deferred compensation costs totaling $203,000 for the year ended December 31, 1998. Compensation cost is the difference between the exercise price and the deemed fair value at the date of grant. Compensation cost is being amortized over the vesting period relating to these options, of which no amount was amortized for the years ended December 31, 2003 and 2002, and $107,000 was amortized for the year ended December 31, 2001.

     Certain Pro Forma Disclosures

      As required under Statement of Financial Accounting Standards No. 123 (SFAS 123), “Accounting for Stock-Based Compensation,” and Statement of Financial Accounting Standards No. 148 (SFAS 148), “Accounting for Stock-Based Compensation Transition and Disclosure,” the pro forma effects of stock-based compensation on net income and net earnings per common share have been estimated at the date of grant using the Black-Scholes option-pricing model.

      The Black-Scholes option-pricing model was developed for use in estimating the fair value of traded options that have no restrictions and are fully transferable and negotiable in a free trading market. Black-Scholes does not consider the employment, transfer or vesting restrictions that are inherent in the Company’s employee options. Use of an option valuation model, as required by SFAS 123, includes highly subjective assumptions based on long-term predictions, including the expected stock price volatility and average life of each option grant. Because the Company’s employee options have characteristics significantly different from those of freely traded options, and because changes in the assumptions underlying the option-pricing model can materially affect the Company’s estimate of the fair value of those options, in the Company’s opinion, the existing valuation models, including Black-Scholes, are not reliable single measures and may misstate the fair value of the Company’s employee options.

59


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      The Company calculated the fair value of each option grant on the date of grant using the Black-Scholes option pricing model as prescribed by SFAS No. 123 using the following assumptions:

                         
Years Ended December 31,

2003 2002 2001



Risk free interest rate
    2.9 %     3.0 %     3.9 %
Expected life (in years)
    5.0       5.0       5.0  
Dividend yield
    0.0 %     0.0 %     0.0 %
Volatility
    109.0 %     101.0 %     104.0 %

      The weighted average grant-date fair value of options granted during the year ended December 31, 2003 was $1.19, $2.39 in 2002 and $12.97 in 2001.

      Had compensation cost for the Company’s options been determined based on the fair value at the grant dates, as prescribed in SFAS 123 and SFAS 148, the Company’s pro forma net earnings and net earnings per share would have been as summarized below (in thousands except per share data):

                             
Years Ended December 31,

2003 2002 2001



Net loss:
                       
 
As reported
  $ (26,731 )   $ (81,181 )   $ (4,996 )
 
Pro forma option expense
    7,323       9,182       7,046  
 
Pro forma net loss
  $ (34,054 )   $ (90,363 )   $ (12,042 )
Net loss per share:
                       
 
As reported:
                       
   
Basic
  $ (1.18 )   $ (3.63 )   $ (0.23 )
   
Diluted
    (1.18 )     (3.63 )     (0.23 )
 
Pro forma net loss:
                       
   
Basic
  $ (1.49 )   $ (4.04 )   $ (0.54 )
   
Diluted
    (1.49 )     (4.04 )     (0.54 )

      Because additional option grants are expected to be made each year, the above pro forma disclosures are not representative of pro forma effects on reported net income for future years.

     Employee Stock Purchase Plan

      In February 1998, the Company’s board of directors approved the 1998 Employee Stock Purchase Plan (the “1998 Purchase Plan”). The Company’s stockholders approved the 1998 Purchase Plan in March 1998. At December 31, 2003 a total of 900,000 shares of the Company’s common stock were reserved for issuance under the 1998 Purchase Plan. A total of 683,000 shares were purchased as of December 31, 2003. The 1998 Purchase Plan permits eligible employees to acquire shares of the Company’s common stock through payroll deductions. The common stock purchase price is determined as 85.0% of the lower of the market price of the common stock at the purchase date or the date of offer to the employee.

     Retirement Savings Plan

      The Company has a 401(k) Savings Plan (the “Savings Plan”) which qualifies as a thrift plan under Section 401(k) of the Internal Revenue Code. All full-time U.S. employees are eligible to participate in the Savings Plan after 90 days from the date of hire. Participants may contribute up to 10.0% of their earnings to the Savings Plan with a discretionary matching amount provided by the Company. The Company’s

60


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

contributions to the Savings Plan were $191,000 for the year ended December 31, 2003, $315,000 for 2002 and $456,000 for 2001.

 
Note 14. Voluntary Stock Option Exchange Program

      On May 27, 2003, the Company announced a voluntary stock option exchange program for our employees. Under the program, option holders, excluding our executive officers and independent directors, had the opportunity to cancel outstanding options with an exercise price in excess of $2.10 per share in exchange for new options to be granted at a future date that was at least six months and one day after the date of cancellation, which was June 30, 2003. The number of shares of common stock subject to the new options was equal to 75% of the number subject to the exchanged options. Under the exchange program, options to purchase an aggregate of 738,027 shares of our common stock, representing approximately 48% of the options that were eligible to be tendered in the Offer as of May 27, 2003, were tendered and cancelled. New options will vest at the same rate as the exchanged options and have an exercise price equal to the fair market value of our common stock at the new grant date, which was $3.11 per share. On December 31, 2003, the Company granted options to purchase an aggregate of 522,754 shares of our common stock in exchange for such tendered options.

 
Note 15. Segment and Foreign Operations Information

      The Company has one operating segment comprising of the design, development, manufacture and distribution of high-performance compound semiconductor substrates.

      The Company sells its substrates products in the United States and in other parts of the world. Also, the Company has operations in Japan and China. Revenues by geographic location based on the country of the customer were as follows (in thousands):

                           
Years Ended December 31,

2003 2002 2001



Net revenues:
                       
 
United States
  $ 11,823     $ 25,185     $ 57,137  
 
Europe
    5,638       5,508       21,341  
 
Canada
    186       1,023       6,643  
 
Taiwan
    7,055       4,246       10,441  
 
Japan
    4,167       3,000       8,355  
 
Asia Pacific (excluding Japan and Taiwan)
    5,844       5,903       4,883  
     
     
     
 
 
Consolidated
  $ 34,713     $ 44,865     $ 108,800  
     
     
     
 

      Property, plant and equipment by geographic location is summarized below (in thousands):

                   
Years Ended
December 31,

2003 2002


Property, plant and equipment, net:
               
 
United States
  $ 7,583     $ 21,133  
 
China
    14,212       18,849  
     
     
 
    $ 21,795     $ 39,982  
     
     
 

61


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

 
Note 16. Related Party Transactions

      Since January 2002, there has not been, nor is there currently proposed, any transaction or series of similar transactions to which the Company was or is to be a party in which the amount involved exceeds $60,000, and in which any director, executive officer or holder of more than 5% of any class of the Company’s voting securities or members of that person’s immediate family had or will have a direct or indirect material interest other than the transactions described below.

      The Company entered into an operating lease in July 2001 for warehouse space in Fremont, CA with 4160 Business Center, LLC, a real estate holding company, in which Davis Zhang, the president of our substrate division, is the sole shareholder. Lease payments to 4160 Business Center, LLC were approximately $121,000 for the three months ended March 31, 2003. In April of 2003, Mr. Zhang sold this warehouse to a party unrelated to the Company. The Company began leasing this warehouse from the new owner on the date of sale. Mr. Zhang will continue to hold a $3.7 million note on the property through April 2005.

 
Note 17. Commitments and Contingencies

      From time to time we are involved in judicial or administrative proceedings concerning matters arising in the ordinary course of our business. We do not expect that any of these matters, individually or in the aggregate, will have a material adverse effect on our business, financial condition, cash flows or results of operation.

      On April 15, 2003, Sumitomo Electric Industries, Ltd., (SEI) filed a complaint in the Tokyo District Court, Civil Division against us and our Japanese distributor alleging patent infringement of two patents held by SEI in Japan. The suit seeks penalties from AXT in the amount of $1.67 million plus interest and court costs and the cessation of AXT’s sales of gallium arsenide substrates in Japan. AXT intends to defend itself vigorously in these lawsuits and continues to sell its products in Japan.

      On June 11, 2003, Cree, Inc. filed a complaint in the United States Court for Northern District of California against the Company alleging patent infringement. The complaint sought damages and injunction against infringement. On July 23, 2003, the Company filed a counter complaint in the United States Court for Northern District of California, denying any patent infringement and alleging that Cree’s actions were intentionally designed to interfere with the Company’s prospective business relationships. The Company reached an agreement with Cree resolving the disputes between us and signed a settlement agreement on March 5, 2004. The resolution of the disputes did not have a material adverse impact on the Company’s consolidated financial position or results of operations.

      The Company has entered into contracts to supply several large customers with GaAs wafers. The contracts guarantee the delivery of a certain number of wafers between January 1, 2001 and December 31, 2004 with a current contract value of $2.0 million. The contract sales prices are subject to review quarterly and can be adjusted in the event that raw material prices change. In the event of non-delivery of the determined wafer quantities in any monthly delivery period, the Company could be subject to non-performance penalties of between 5% and 10% of the value of the delinquent monthly deliveries. The Company has not received any claims for non-performance penalties due to non-delivery. Partial prepayments received for these supply contracts totaling $994,000 are included in accrued liabilities at December 31, 2003. As of December 31, 2003, the Company has met all of its delivery obligations under these contracts and expects to do so for the remainder of the contract terms.

      The Company leases certain office space, manufacturing facilities and property under long-term operating leases expiring at various dates through March 2013. Total rent expense under these operating leases was approximately $1.2 million for the year ended December 31, 2003, $947,000 in 2002 and $779,000 in 2001.

62


Table of Contents

AXT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      The Company has an outstanding purchase order for manufacturing equipment related to its discontinued opto-electronics division totaling $1.4 million at December 31, 2003. The Company is currently negotiating a settlement with the supplier for this un-needed equipment.

      Total minimum lease payments under the above leases as of December 31, 2003, are summarized below (in thousands):

         
Operating
Leases

2004
  $ 1,231  
2005
    1,115  
2006
    836  
2007
    616  
2008
    617  
Thereafter
    3,236  
     
 
    $ 7,651  
     
 

63


Table of Contents

      Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

  AXT, INC.

  By:  /s/ MORRIS S. YOUNG
 
  Morris S. Young,
  Chief Executive Officer and President

Date: March 29, 2004

POWER OF ATTORNEY

      KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Morris S. Young and Donald L. Tatzin, and each of them, his true and lawful attorney-in-fact and agent, with full power of substitution, each with power to act alone, to sign and execute on behalf of the undersigned any and all amendments to this Report on Form 10-K, and to perform any acts necessary in order to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requested and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or their or his or her substitutes, shall do or cause to be done by virtue hereof.

      Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

             
Signature Title Date



 
/s/ MORRIS S. YOUNG

Morris S. Young
  President, Chief Executive Officer and Chairman of the Board   March 29, 2004
 
/s/ DONALD L. TATZIN

Donald L. Tatzin
  Senior Vice President, Chief Financial Officer, Director   March 29, 2004
 
/s/ DAVID C. CHANG

David C. Chang
  Director   March 29, 2004
 
/s/ JESSE CHEN

Jesse Chen
  Director   March 29, 2004
 
/s/ LEONARD LEBLANC

Leonard LeBlanc
  Director   March 29, 2004

64


Table of Contents

AXT, Inc.

EXHIBITS
TO
FORM 10-K ANNUAL REPORT

For the Year Ended December 31, 2003

         
Exhibit
Number Description


  3 .1(3)   Restated Certificate of Incorporation
  3 .2(4)   Certificate of Designation, Preferences and Rights of Series A Preferred Stock (which is incorporated herein by reference to Exhibit 2.1 to the registrant’s form 8-K dated May 28, 1999).
  3 .3(5)   Second Amended and Restated By Laws
  4 .2(5)   Rights Agreement dated April 24, 2001 by and between AXT, Inc. and ComputerShare Trust Company, Inc.
  10 .1(1)   Form of Indemnification Agreement for directors and officers.*
  10 .2(1)   1993 Stock Option Plan and forms of agreements thereunder.*
  10 .3(1)   1997 Stock Option Plan and forms of agreements thereunder.*
  10 .4(1)   1997 Employee Stock Purchase Plan and forms of agreements thereunder.*
  10 .5(1)   1998 Employee Stock Purchase Plan and forms of agreements thereunder.*
  10 .7(2)   Purchase and Sale Agreement by and between Limar Realty Corp. #23 and AXT, Inc. dated April 1998.
  10 .10(3)   Bond Purchase Contract between Dain Rauscher Incorporated and AXT, Inc. dated December 1, 1998.
  10 .11(3)   Remarketing Agreement between Dain Rauscher Incorporated and AXT, Inc. dated December 1, 1998.
  10 .15(7)   Reimbursement Agreement between Wells Fargo Bank National Association and AXT, Inc. dated April 7, 2003.
  10 .16(8)   Asset purchase agreements dated September 4, 2003 by and between Dalian Luming Science and Technology Group, Ltd and AXT, Inc. and by and between Lumei Optoelectronics Corp., AXT, Inc., Lyte Optronics, Inc., Beijing Tongmei Xtal Technology and Xiamen Advanced Semiconductor Co., Ltd.


Table of Contents

         
Exhibit
Number Description


  10 .17   Code of Business Conduct and Ethics dated February 2, 2004.
  21 .1(1)   List of Subsidiaries.
  24 .1   Power of Attorney (see signature page).
  31 .1   Certification by Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  31 .2   Certification by Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  32 .1   Certification by Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  32 .2   Certification by Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


(1)  Incorporated by reference to the exhibit as of the same number as filed with the SEC in our Registration Statement on Form S-1 on March 17, 1998.
(2)  Incorporated by reference to the exhibit as of the same number as filed with the SEC in our Registration Statement on Amendment No. 2 to Form S-1 on May 11, 1998.
(3)  Incorporated by reference to the exhibit as of the same number as filed with the SEC in our Annual Report on Form 10-K for the year ended December 31, 1998
(4)  Incorporated by reference to the exhibit as of the same number as filed with the SEC in our Form 8-K on June 14, 1999
(5)  Incorporated by reference to the exhibit as of the same number as filed with the SEC in our Form 8-K on May 30, 2001
(6)  Incorporated by reference to the exhibit as of the same number as filed with the SEC in our Form 10Q on November 12, 2002
(7)  Incorporated by reference to the exhibit as of the same number as filed with the SEC in our Form 10Q on May 9, 2003
(8)  Incorporated by reference to the exhibit as of the same number as filed with the SEC in our Form 10Q on November 13, 2003
  Indicates a management contract